Contact
searchSearch
HMP Global
Login

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

a caregiver speaks with a doctor
News
Caregivers Confirm Usability of Schizophrenia Cognition Rating Scale
11/14/2024
A qualitative study involving unpaid and professional caregivers of patients with schizophrenia confirmed the content and usability of the Schizophrenia Cognition Rating Scale (SCoRS).
A qualitative study involving unpaid and professional caregivers of patients with schizophrenia confirmed the content and usability of the Schizophrenia Cognition Rating Scale (SCoRS).
A qualitative study involving...
11/14/2024
Psych Congress Network
Desiree Matthews
Schizophrenia Conference Insights
New Class of Medication Offers Innovative Treatment for Schizophrenia Symptoms
11/07/2024
Watch these exclusive insights with Desiree Matthews, PMHNP-BC, to learn how this novel treatment could reshape the landscape of care for adults living with schizophrenia.
Watch these exclusive insights with Desiree Matthews, PMHNP-BC, to learn how this novel treatment could reshape the landscape of care for adults living with schizophrenia.
Watch these exclusive insights...
11/07/2024
Psych Congress Network
Patient survey
News
Patient Survey Identifies Barriers to TD Treatment
11/06/2024
Key barriers to tardive dyskinesia (TD) diagnosis include a lack of communication with the health care professional, lack of a physical exam, and low educational and socioeconomic status, according to a survey of adults with TD symptoms.
Key barriers to tardive dyskinesia (TD) diagnosis include a lack of communication with the health care professional, lack of a physical exam, and low educational and socioeconomic status, according to a survey of adults with TD symptoms.
Key barriers to tardive...
11/06/2024
Psych Congress Network
depression stock photo
News
Add-on Lumateperone Eases MDD in Patients With Inadequate Antidepressant Response
11/04/2024
Adjunctive treatment with the atypical antipsychotic lumateperone improved depressive symptoms and severity more than adjunctive placebo in patients with MDD with inadequate response to previous antidepressant therapy, according to a poster...
Adjunctive treatment with the atypical antipsychotic lumateperone improved depressive symptoms and severity more than adjunctive placebo in patients with MDD with inadequate response to previous antidepressant therapy, according to a poster...
Adjunctive treatment with the...
11/04/2024
Psych Congress Network
Marc Agronin
Videos
Implementing Alzheimer Disease Prevention Practices
11/02/2024
Dr Marc Agronin discusses some easy prevention strategies for Alzheimer disease following his Psych Congress 2024 session "A New Era for Alzheimer’s Disease: Prevention, Early Diagnosis, Effective Intervention."
Dr Marc Agronin discusses some easy prevention strategies for Alzheimer disease following his Psych Congress 2024 session "A New Era for Alzheimer’s Disease: Prevention, Early Diagnosis, Effective Intervention."
Dr Marc Agronin discusses some...
11/02/2024
Psych Congress Network
Conference presenter
News
Olanzapine/Samidorphan Demonstrates Favorable Safety Profile in 4-Year Open-Label Study
11/01/2024
Combination olanzapine/samidorphan (OLZ/SAM) maintained consistent symptom control in patients with schizophrenia or bipolar I disorder and demonstrated a favorable long-term safety profile over 4 years consistent with previous studies.
Combination olanzapine/samidorphan (OLZ/SAM) maintained consistent symptom control in patients with schizophrenia or bipolar I disorder and demonstrated a favorable long-term safety profile over 4 years consistent with previous studies.
Combination...
11/01/2024
Psych Congress Network
Michelle Martel, PhD
Q&As
When It Comes to ADHD in Women, There's Still So Much to Learn
10/31/2024
Michelle Martel, PhD, shares insights from her session on ADHD in women presented at the 2024 Psych Congress.
Michelle Martel, PhD, shares insights from her session on ADHD in women presented at the 2024 Psych Congress.
Michelle Martel, PhD, shares...
10/31/2024
Psych Congress Network
Andrew Penn
Q&As
Psychedelics: New Research, Regulations, and Horizons
10/30/2024
"Psychedelic therapies must continue to be researched so that perhaps, someday with their help, we will be able to help our patients live their best lives," Andrew Penn, PMHNP-BC.
"Psychedelic therapies must continue to be researched so that perhaps, someday with their help, we will be able to help our patients live their best lives," Andrew Penn, PMHNP-BC.
"Psychedelic therapies must...
10/30/2024
Psych Congress Network
Jo Hughes
Q&As
Unpacking the Pressing Challenges of Polypharmacy in Psychiatry
10/30/2024
Jo Hughes, DMSc, PA-C, CAQ-PSY, discusses the complexities of polypharmacy in psychiatry and the balance between medication management and patient safety.
Jo Hughes, DMSc, PA-C, CAQ-PSY, discusses the complexities of polypharmacy in psychiatry and the balance between medication management and patient safety.
Jo Hughes, DMSc, PA-C, CAQ-PSY,...
10/30/2024
Psych Congress Network
Beau Kilmer, PhD
Q&As
Psychedelic Policy and Market Considerations
10/28/2024
Dr Kilmer discusses the psychedelic market in the United States, policy on both state and local levels, and the role of the federal government in regulation.
Dr Kilmer discusses the psychedelic market in the United States, policy on both state and local levels, and the role of the federal government in regulation.
Dr Kilmer discusses the...
10/28/2024
Psych Congress Network
Christoph Correll, MD.
Videos
Strategies to Manage Adverse Effects From Schizophrenia Treatment
10/28/2024
Christoph Correll, MD, offers clinical guidance for managing adverse affects from schizophrenia treatment, including weight gain and movement disorder
Christoph Correll, MD, offers clinical guidance for managing adverse affects from schizophrenia treatment, including weight gain and movement disorder
Christoph Correll, MD, offers...
10/28/2024
Psych Congress Network
Christoph Correll, MD
Videos
Beyond D2 Receptor Manipulation: Novel Agents for Schizophrenia Treatment
10/16/2024
Christoph Correll, MD, provides a thorough pharmacological overview of the traditional and novel treatments available for schizophrenia.
Christoph Correll, MD, provides a thorough pharmacological overview of the traditional and novel treatments available for schizophrenia.
Christoph Correll, MD, provides...
10/16/2024
Psych Congress Network
Christoph Correll, MD
Videos
Recognizing the Early Indicators of Schizophrenia
10/08/2024
Christoph Correll, MD, reviews some of the key prodromal and accentuated psychotic symptoms that serve as early indicators of schizophrenia.
Christoph Correll, MD, reviews some of the key prodromal and accentuated psychotic symptoms that serve as early indicators of schizophrenia.
Christoph Correll, MD, reviews...
10/08/2024
Psych Congress Network
Timothy Wilens, MD
Videos
Managing Life Transitions in ADHD: Why Early Preparation is Critical
09/18/2024
Timothy Wilens, MD, provides practical clinical guidance for supporting patients with ADHD through life transitions.
Timothy Wilens, MD, provides practical clinical guidance for supporting patients with ADHD through life transitions.
Timothy Wilens, MD, provides...
09/18/2024
Psych Congress Network
Julie Carbray, PhD
Videos
Updates in Bipolar Disorder Treatment
07/31/2024
Join Dr Julie Carbray as she delves into the recent advancements and emerging therapies in bipolar disorder treatment.
Join Dr Julie Carbray as she delves into the recent advancements and emerging therapies in bipolar disorder treatment.
Join Dr Julie Carbray as she...
07/31/2024
Psych Congress Network
Chepke
Videos
Differential Diagnosis of Tardive Dyskinesia and Other Movement Disorders
07/09/2024
Craig Chepke, MD, DFAPA, shares the importance of differentiating tardive dyskinesia (TD) from other movement disorders .
Craig Chepke, MD, DFAPA, shares the importance of differentiating tardive dyskinesia (TD) from other movement disorders .
Craig Chepke, MD, DFAPA, shares...
07/09/2024
Psych Congress Network
Penn and Jain
Videos
Healing Health Care Burnout and Lessons Learned From the COVID-19 Pandemic
04/16/2024

Featuring Saundra Jain, MA, PsyD, LPC, and Andrew Penn, MS, PMHNP

Featuring Saundra Jain, MA, PsyD, LPC...
Saundra Jain, MA, PsyD, LPC, and Andrew Penn, MS, PMHNP, unpack the profound and lasting impacts of burnout among health care professionals in the wake of the COVID-19 pandemic.
Saundra Jain, MA, PsyD, LPC, and Andrew Penn, MS, PMHNP, unpack the profound and lasting impacts of burnout among health care professionals in the wake of the COVID-19 pandemic.
Saundra Jain, MA, PsyD, LPC, and...
04/16/2024
Psych Congress Network
John Grant, MD
Your Questions Answered
Distinguishing Visual Hallucinations, OCD Imagery, and Anxiety
03/28/2024

Featuring John Grant, MD

Featuring John Grant, MD
John Grant, MD, explores previously unanswered audience Q&A questions from his live Psych Congress 2023 session regarding differentiating between visual hallucinations and OCD imagery and between OCD and anxiety.
John Grant, MD, explores previously unanswered audience Q&A questions from his live Psych Congress 2023 session regarding differentiating between visual hallucinations and OCD imagery and between OCD and anxiety.
John Grant, MD, explores...
03/28/2024
Psych Congress Network
a doctor and patient sit on couches talking
News
aLAIs a Useful Treatment Option for Schizophrenia, Study Results Underscore
01/05/2024
Atypical long-acting injectable (aLAI) antipsychotic medications are useful for the treatment of schizophrenia, especially in patients who experienced persistent psychotic symptoms and had trouble maintaining consistent adherence.
Atypical long-acting injectable (aLAI) antipsychotic medications are useful for the treatment of schizophrenia, especially in patients who experienced persistent psychotic symptoms and had trouble maintaining consistent adherence.
Atypical long-acting injectable...
01/05/2024
Psych Congress Network
Adding Drug-Drug Interactions, Lifestyle Factors Boosts Pharmacogenomics Guidance
News
Adding Drug-Drug Interactions, Lifestyle Factors Boosts Pharmacogenomics Guidance
12/04/2023
Incorporating drug-drug interactions and lifestyle factors into pharmacogenomics-guided medication management contributed to improved remission rates in patients with major depressive disorder, according to a poster presentation at Psych...
Incorporating drug-drug interactions and lifestyle factors into pharmacogenomics-guided medication management contributed to improved remission rates in patients with major depressive disorder, according to a poster presentation at Psych...
Incorporating drug-drug...
12/04/2023
Psych Congress Network
pop quiz
Quiz
Which sleep disturbance is most strongly predictive of MDD recurrence?
11/07/2023
11/07/2023
Psych Congress Network
stock depression
Conference Poster Highlight
Sleep Disturbances Associated With MDD Recurrence Over 3 Years
10/31/2023
Hypersomnolence, insomnia, and sleep dissatisfaction predicted the recurrence of MDD over 3 years, according to a poster presentation at Psych Congress.
Hypersomnolence, insomnia, and sleep dissatisfaction predicted the recurrence of MDD over 3 years, according to a poster presentation at Psych Congress.
Hypersomnolence, insomnia, and...
10/31/2023
Psych Congress Network
Dr Ahmed Baig
Videos
Enhancing Depression Treatment: Rapid-Acting Antidepressants Accelerate Onset of Relief
10/30/2023
Dr Ahmed Baig on novel mechanisms of action in depression treatment.
Dr Ahmed Baig on novel mechanisms of action in depression treatment.
Dr Ahmed Baig on novel...
10/30/2023
Psych Congress Network
schizophrenia treatment
News
TV-46000 Demonstrates Prolonged Schizophrenia Relapse Prevention, SHINE Study Finds
10/25/2023
TV-46000, a long-acting subcutaneous antipsychotic (LASCA), exhibits a favorable long-term benefit-risk profile for patients with schizophrenia, according to study results presented in a poster at Psych Congress 2023.
TV-46000, a long-acting subcutaneous antipsychotic (LASCA), exhibits a favorable long-term benefit-risk profile for patients with schizophrenia, according to study results presented in a poster at Psych Congress 2023.
TV-46000, a long-acting...
10/25/2023
Psych Congress Network
depression stock photo
Psych Congress Poster Brief
MDD Symptom Improvements With Zuranolone Extend to Daily Lives, Responders Report
10/10/2023
Patients with MDD who responded to treatment with zuranolone said they experienced rapid improvement in depressive symptoms and in their daily lives, Psych Congress poster states.
Patients with MDD who responded to treatment with zuranolone said they experienced rapid improvement in depressive symptoms and in their daily lives, Psych Congress poster states.
Patients with MDD who responded...
10/10/2023
Psych Congress Network
Dr Chepke
Videos
Advancements in Tardive Dyskinesia Understanding and Management
10/01/2023
Craig Chepke, MD, DFAPA, discusses the latest advancements in the understanding of tardive dyskinesia and how clinicians can adapt their assessment and management strategies with this updated knowledge.
Craig Chepke, MD, DFAPA, discusses the latest advancements in the understanding of tardive dyskinesia and how clinicians can adapt their assessment and management strategies with this updated knowledge.
Craig Chepke, MD, DFAPA,...
10/01/2023
Psych Congress Network
Veronica Ridpath, DO.
Schizophrenia Insights
LAIs Are Not a Last Resort in Schizophrenia Treatment, Expert Says
09/27/2023
Veronica Ridpath, DO, addresses clinician bias towards the use of long-acting injectables for schizophrenia treatment.
Veronica Ridpath, DO, addresses clinician bias towards the use of long-acting injectables for schizophrenia treatment.
Veronica Ridpath, DO, addresses...
09/27/2023
Psych Congress Network
Edward Kaftarian, MD.
Videos
Update on Prescribing via Telehealth: Potential Changes in the Drug Enforcement Administration’s Guidelines
09/20/2023
Edward Kaftarian, MD, shares his thoughts on the potential approaches to telehealth prescribing the DEA may implement once the Ryan Haight Act waivers expire on November 11, 2023.
Edward Kaftarian, MD, shares his thoughts on the potential approaches to telehealth prescribing the DEA may implement once the Ryan Haight Act waivers expire on November 11, 2023.
Edward Kaftarian, MD, shares his...
09/20/2023
Psych Congress Network
Christoph Correll, MD
Schizophrenia Insights
Why Early Identification is Key to Functional Recovery in Schizophrenia
09/14/2023
Christoph Correll, MD, discusses why early intervention in schizophrenia is key to effective treatment and functional recovery.
Christoph Correll, MD, discusses why early intervention in schizophrenia is key to effective treatment and functional recovery.
Christoph Correll, MD, discusses...
09/14/2023
Psych Congress Network
Dr Charles DeBattista Stanford University
MDD Conference Insights
Unmet Needs in MDD Treatment With Dr Charles DeBattista
09/13/2023
Dr Charles DeBattista, professor of psychiatry and behavioral sciences at Stanford University, discusses the evolving landscape of MDD treatment while on-site at Psych Congress 2023.
Dr Charles DeBattista, professor of psychiatry and behavioral sciences at Stanford University, discusses the evolving landscape of MDD treatment while on-site at Psych Congress 2023.
Dr Charles DeBattista, professor...
09/13/2023
Psych Congress Network
News
Viloxazine ER Added to Stimulant Treatment for Pediatric ADHD Appears Safe, Effective
09/09/2023
Extended-release viloxazine administered with stimulant medication improved symptoms of ADHD in pediatric patients with an initial inadequate response to stimulant medication, according to a poster presentation at Psych Congress. 
Extended-release viloxazine administered with stimulant medication improved symptoms of ADHD in pediatric patients with an initial inadequate response to stimulant medication, according to a poster presentation at Psych Congress. 
Extended-release viloxazine...
09/09/2023
Psych Congress Network
News
Anhedonia Linked With Worse Depression, Indicating Possible Unmet Need
09/09/2023
Higher anhedonia scores were significantly associated with greater levels of depression and anxiety in adults with MDD, according to a poster presentation at Psych Congress 2023 in Nashville, Tennessee.
Higher anhedonia scores were significantly associated with greater levels of depression and anxiety in adults with MDD, according to a poster presentation at Psych Congress 2023 in Nashville, Tennessee.
Higher anhedonia scores were...
09/09/2023
Psych Congress Network
Manpreet Singh, MD, MS.
Current Clinical Insights Into Pediatric Anxiety Disorders
09/09/2023
Manpreet Singh, MD, MS, shares insights from her Psych Congress 2023 session on pediatric anxiety disorders.
Manpreet Singh, MD, MS, shares insights from her Psych Congress 2023 session on pediatric anxiety disorders.
Manpreet Singh, MD, MS, shares...
09/09/2023
Psych Congress Network
Julie Carbray, PhD
Q&As
Addressing Common Clinical Challenges in ADHD Treatment
09/08/2023
Julie Carbray, PhD, APRN, discusses her Psych Congress 2023 session on optimizing ADHD treatment.
Julie Carbray, PhD, APRN, discusses her Psych Congress 2023 session on optimizing ADHD treatment.
Julie Carbray, PhD, APRN,...
09/08/2023
Psych Congress Network
zimmerman
Q&As
Depressive Mixed States: Diagnosis, Treatment, and Strategies
09/07/2023
Depressive Mixed States (DMX) is a new specifier listed in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), and describes when patients experience both depressive symptoms and symptoms of mania or hypomania...
Depressive Mixed States (DMX) is a new specifier listed in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), and describes when patients experience both depressive symptoms and symptoms of mania or hypomania...
Depressive Mixed States (DMX) is...
09/07/2023
Psych Congress Network
Christine Moutier, MD, Chief Medical Officer for the American Foundation for Suicide Prevention (AFSP).
News
Transformative ‘Talk Therapy:’ Psych Congress Keynote Considers Medicinal Music
09/07/2023
The 36th Annual Psych Congress meeting convened on Wednesday, September 6th, in Nashville, Tennessee, with a robust pre-conference program that concluded with the second-ever Eric C. Arauz Memorial Keynote Address.
The 36th Annual Psych Congress meeting convened on Wednesday, September 6th, in Nashville, Tennessee, with a robust pre-conference program that concluded with the second-ever Eric C. Arauz Memorial Keynote Address.
The 36th Annual Psych Congress...
09/07/2023
Psych Congress Network
Vladimir Maletic, MD, MS.
Videos
Loneliness, Social Isolation, and Major Depressive Disorder
09/06/2023
While psychotherapy, psychosocial treatments, and psychopharmacology have been the standard treatment for major depressive disorder (MDD), social ties also play a significant role in determining whether or not patients can achieve remission.
While psychotherapy, psychosocial treatments, and psychopharmacology have been the standard treatment for major depressive disorder (MDD), social ties also play a significant role in determining whether or not patients can achieve remission.
While psychotherapy,...
09/06/2023
Psych Congress Network
Psych Congress Partners With AFSP to Enhance Mental Health Education and Community Support
News
Psych Congress Partners With AFSP to Enhance Mental Health Education and Community Support
09/05/2023
HMP Global, a health care events and education company, has unveiled an expanded partnership between the annual Psych Congress national meeting and the American Foundation for Suicide Prevention (AFSP).
HMP Global, a health care events and education company, has unveiled an expanded partnership between the annual Psych Congress national meeting and the American Foundation for Suicide Prevention (AFSP).
HMP Global, a health care events...
09/05/2023
Psych Congress Network
Experts Convene in Nashville at Psych Congress 2023 to Address Rising Concerns in MDD Treatment
News
Experts Convene in Nashville at Psych Congress 2023 to Address Rising Concerns in MDD Treatment
09/05/2023
Psych Congress will celebrate 36 years of delivering practical, case-based education to psychiatrists, nurse practitioners, physician assistants, and other mental health professionals, from September 6-10 in Nashville, Tennessee. 
Psych Congress will celebrate 36 years of delivering practical, case-based education to psychiatrists, nurse practitioners, physician assistants, and other mental health professionals, from September 6-10 in Nashville, Tennessee. 
Psych Congress will celebrate 36...
09/05/2023
Psych Congress Network
Dr Greg Mattingly
Videos
Understanding the Stimulant Shortage
09/05/2023
Dr Mattingly explains the stimluant shortage and what clinicians can do to help their patients.
Dr Mattingly explains the stimluant shortage and what clinicians can do to help their patients.
Dr Mattingly explains the...
09/05/2023
Psych Congress Network
Psych Congress Pre-Conference to Explore Reproductive Psychiatry and Perinatal Mental Health
Videos
Psych Congress Pre-Conference to Explore Reproductive Psychiatry and Perinatal Mental Health
08/22/2023
This year’s Psych Congress pre-conference session, created in partnership with the International Society for Reproductive Psychiatry (ISRP), promises an enriched understanding of women's health and reproductive psychiatry across the life...
This year’s Psych Congress pre-conference session, created in partnership with the International Society for Reproductive Psychiatry (ISRP), promises an enriched understanding of women's health and reproductive psychiatry across the life...
This year’s Psych Congress...
08/22/2023
Psych Congress Network
How ADHD Presentation Shifts From Adolescence to Adulthood
Videos
"Unmasking" ADHD in Aging Patients With Comorbidities
07/11/2023
Vladimir Maletic, MD, Psych Congress Network ADHD section editor, previews his Psych Congress 2023 session "Is It ADHD or Something Else? Understanding Nuances of the Differential Diagnosis."
Vladimir Maletic, MD, Psych Congress Network ADHD section editor, previews his Psych Congress 2023 session "Is It ADHD or Something Else? Understanding Nuances of the Differential Diagnosis."
Vladimir Maletic, MD, Psych...
07/11/2023
Psych Congress Network
Dr Leslie Citrome
Videos
Treating Agitation in Bipolar Disorder: Challenges and Clinical Pearls
05/19/2023
In this clip from Psych Congress 2022, Leslie Citrome, MD, clinical professor at New York Medical College, discusses the challenges of treating agitation in patients with bipolar disorder and schizophrenia.
In this clip from Psych Congress 2022, Leslie Citrome, MD, clinical professor at New York Medical College, discusses the challenges of treating agitation in patients with bipolar disorder and schizophrenia.
In this clip from Psych Congress...
05/19/2023
Psych Congress Network
Dr Jody Russon
Videos
Better Treatment Through Understanding Suicide in LGBTQIA+ Community
04/06/2023
In this clip from Psych Congress 2022 in New Orleans, Louisiana, Jody Russon, PhD, discusses the theories that can help clinicians better understand the concern of suicide in the LGBTQIA+ community.
In this clip from Psych Congress 2022 in New Orleans, Louisiana, Jody Russon, PhD, discusses the theories that can help clinicians better understand the concern of suicide in the LGBTQIA+ community.
In this clip from Psych Congress...
04/06/2023
Psych Congress Network
Dr Tim Wilens
Videos
Major Impacts of Untreated ADHD Across a Patient’s Lifespan
04/06/2023
What happens when patients with attention-deficit/hyperactivity disorder (ADHD) don't get the treatment they need?
What happens when patients with attention-deficit/hyperactivity disorder (ADHD) don't get the treatment they need?
What happens when patients with...
04/06/2023
Psych Congress Network
Dr Podesta
Videos
Treating Bipolar Disorder as a Comorbidity of SUD
03/23/2023
In this clip from Psych Congress 2022 in Dr Arwen Podesta, discusses how to treat comorbid disorders with SUDs and what clinicians should prioritize.
In this clip from Psych Congress 2022 in Dr Arwen Podesta, discusses how to treat comorbid disorders with SUDs and what clinicians should prioritize.
In this clip from Psych Congress...
03/23/2023
Psych Congress Network
Dr Podesta
Videos
Substance Use Disorder Treatment Trends and Hurdles
03/15/2023
In this clip from Psych Congress 2022 in New Orleans, Louisiana, Dr Arwen Podesta, board-certified adult psychiatrist at Podesta Psychiatry LLC, discusses 2022 trends in substance use.
In this clip from Psych Congress 2022 in New Orleans, Louisiana, Dr Arwen Podesta, board-certified adult psychiatrist at Podesta Psychiatry LLC, discusses 2022 trends in substance use.
In this clip from Psych Congress...
03/15/2023
Psych Congress Network
Which comorbid disorder should be stabilized first?
Expert Insights Quiz
Which comorbid disorder should be stabilized first?
03/07/2023
Time for a pop quiz!
Time for a pop quiz!
Time for a pop quiz!
03/07/2023
Psych Congress Network
Dr Christoph U. Correll
Videos
How to Treat Bipolar Disorder When Depressive Episodes Are Present
03/01/2023
In this clip from Psych Congress 2022 in New Orleans, Louisiana, Christoph U. Correll, MD, discusses identifying bipolar depression in treatment.
In this clip from Psych Congress 2022 in New Orleans, Louisiana, Christoph U. Correll, MD, discusses identifying bipolar depression in treatment.
In this clip from Psych Congress...
03/01/2023
Psych Congress Network
Dr Julie A Carbray
Videos
Managing Medication Side Effects in Bipolar Disorder Treatment
02/21/2023
In the treatment of bipolar disorder, managing medication side effects can be a "game-changer," according to Julie Carbray, PhD, PMHNP-BC, PMHCNS-BC, APRN.
In the treatment of bipolar disorder, managing medication side effects can be a "game-changer," according to Julie Carbray, PhD, PMHNP-BC, PMHCNS-BC, APRN.
In the treatment of bipolar...
02/21/2023
Psych Congress Network
Sara Schley, MBA
Patient Perspective Video
Asking the Right Questions During Treatment
02/16/2023
Sara Schley discusses how one doctor asking the right questions helped her finally find the right treatment, from her experience as a patient with bipolar disorder.
Sara Schley discusses how one doctor asking the right questions helped her finally find the right treatment, from her experience as a patient with bipolar disorder.
Sara Schley discusses how one...
02/16/2023
Psych Congress Network
What is the relationship between ADHD and bipolar disorder?
Videos
What is the relationship between ADHD and bipolar disorder?
01/23/2023
Tim Wilens, MD, Massachusetts General Hospital, discusses the connection between bipolar disorder and ADHD and how clinicians should best approach treatment.
Tim Wilens, MD, Massachusetts General Hospital, discusses the connection between bipolar disorder and ADHD and how clinicians should best approach treatment.
Tim Wilens, MD, Massachusetts...
01/23/2023
Psych Congress Network
Edward Kaftarian, MD.
Videos
Contraindications in Telepsychiatry
01/04/2023
Edward Kaftarian, MD, discusses which disease states providers might find challenging to treat via telehealth.
Edward Kaftarian, MD, discusses which disease states providers might find challenging to treat via telehealth.
Edward Kaftarian, MD, discusses...
01/04/2023
Psych Congress Network
Sara Schley, MBA
PATIENT PERSPECTIVE VIDEO
Getting the Diagnosis Right: How Clinicians Can Best Listen to Their Patients
12/21/2022
At this year's Psych Congress in New Orleans, Louisiana, Sara Schley, MBA, CEO and co-founder of Seed Systems and peer support advocate, shared her perspective as a patient with long-misdiagnosed bipolar disorder.
At this year's Psych Congress in New Orleans, Louisiana, Sara Schley, MBA, CEO and co-founder of Seed Systems and peer support advocate, shared her perspective as a patient with long-misdiagnosed bipolar disorder.
At this year's Psych Congress in...
12/21/2022
Psych Congress Network
Leslie Citrome, MD, MPH.
Schizophrenia Insights
Addressing Agitation Through a Collaborative Conversation
11/14/2022
Section Editor Leslie Citrome, MD, MPH, discuss his clinical approach to handling patient agitation, including presenting patients with a range of medication administration options from oral to intramuscular injection.
Section Editor Leslie Citrome, MD, MPH, discuss his clinical approach to handling patient agitation, including presenting patients with a range of medication administration options from oral to intramuscular injection.
Section Editor Leslie Citrome,...
11/14/2022
Psych Congress Network
Dr Gregory Mattingly
Videos
Taking Patients’ "Pulse" With Vital Statistics in Mental Health Treatment
11/04/2022
Psych Congress Network sat down with Dr Mattingly after his Psych Congress 2022 session to hear what else he had to say about the "vital statistics" clinicians should use in mental health treatment. 
Psych Congress Network sat down with Dr Mattingly after his Psych Congress 2022 session to hear what else he had to say about the "vital statistics" clinicians should use in mental health treatment. 
Psych Congress Network sat down...
11/04/2022
Psych Congress Network
From DepressionCare360
Tackling Depression With Psychedelic-Assisted Therapies
11/02/2022
Andrew Penn, MS, PMHNP, explains why psychedelic-assisted therapies are a great option for treating depression.
Andrew Penn, MS, PMHNP, explains why psychedelic-assisted therapies are a great option for treating depression.
Andrew Penn, MS, PMHNP, explains...
11/02/2022
Psych Congress Network
Dr Christoph Correll
Videos
For Effective Communication in Treatment, Center the Person, Not the Illness
10/24/2022
According to Christoph Correll, MD, "a medication is a communication." When treating patients with mental illness, it is important to maintain a healthy level of effective conversation.
According to Christoph Correll, MD, "a medication is a communication." When treating patients with mental illness, it is important to maintain a healthy level of effective conversation.
According to Christoph Correll,...
10/24/2022
Psych Congress Network
Quiz
What are some of the challenges of telehealth treatment?
10/24/2022
Time for a pop quiz! How much do you know about telemedicine?
Time for a pop quiz! How much do you know about telemedicine?
Time for a pop quiz! How much do...
10/24/2022
Psych Congress Network
pop quiz.
Quiz
Which Treatment Outcomes Do Patients Care About The Most?
10/20/2022
Take the quiz to test your clinical knowledge!
Take the quiz to test your clinical knowledge!
Take the quiz to test your...
10/20/2022
Psych Congress Network
Edward Kaftarian
Podcasts
Which Pandemic Prompted Telehealth Waivers Are Still in Effect? With Dr Edward Kaftarian
10/19/2022
Telehealth waivers implemented in response to the pandemic may no longer be in effect, and clinicians should take steps to stay informed.
Telehealth waivers implemented in response to the pandemic may no longer be in effect, and clinicians should take steps to stay informed.
Telehealth waivers implemented...
10/19/2022
Psych Congress Network
Dr Julie A Carbray
Videos
Ensuring Safety in the Psychopharmacology of Bipolar Disorder
10/14/2022
Steering Committee Member Julie Carbray, PhD, APRN, clinical professor at the University of Illinois at Chicago, discusss how clinicians can ensure patient safety and comfort when treating bipolar disorder with medication. 
Steering Committee Member Julie Carbray, PhD, APRN, clinical professor at the University of Illinois at Chicago, discusss how clinicians can ensure patient safety and comfort when treating bipolar disorder with medication. 
Steering Committee Member Julie...
10/14/2022
Psych Congress Network
kaftarian
Videos
Overcoming the Challenges of Telehealth Treatment 
10/10/2022
In this clip from Psych Congress 2022, Edward Kaftarian, MD, CEO of Orbit Health Telepsychiatry, discusses the obstacles that clinicians face when practicing telemedicine and how they can be mindful of them in the future.
In this clip from Psych Congress 2022, Edward Kaftarian, MD, CEO of Orbit Health Telepsychiatry, discusses the obstacles that clinicians face when practicing telemedicine and how they can be mindful of them in the future.
In this clip from Psych Congress...
10/10/2022
Psych Congress Network
Dr Mark Zimmerman
Videos
Are Non-Symptom Factors Worth Consideration When Determining Patient Treatment Response?
10/05/2022
Dr Zimmerman weighs in on the recent research that patients consider non-symptom factors important in evaluating treatment response.
Dr Zimmerman weighs in on the recent research that patients consider non-symptom factors important in evaluating treatment response.
Dr Zimmerman weighs in on the...
10/05/2022
Psych Congress Network
Dr Christoph Correll
Videos
Using Maintenance Care to Break Through the Complexities of Treating Bipolar Disorder 
10/04/2022
Christoph Correll, MD, professor of psychiatry at Hofstra Northwell School of Medicine, on the key to finding the right treatment: maintenance care.
Christoph Correll, MD, professor of psychiatry at Hofstra Northwell School of Medicine, on the key to finding the right treatment: maintenance care.
Christoph Correll, MD, professor...
10/04/2022
Psych Congress Network
Dr Meyer
Videos
Dr Meyer on the Point of Futility in Treating Schizophrenia
09/26/2022
Jonathan M Meyer, MD, a clinical professor of psychiatry at the University of California, San Diego, talks about why more is not always better.
Jonathan M Meyer, MD, a clinical professor of psychiatry at the University of California, San Diego, talks about why more is not always better.
Jonathan M Meyer, MD, a clinical...
09/26/2022
Psych Congress Network
Dr Julie A Carbray
Videos
How Can Clinicians Better Identify and Diagnose Bipolar Disorder?
09/26/2022
At Psych Congress 2022, PCN sat down with Dr Julie Carbray, clinical professor at the University of Illinois at Chicago and discussed distinguishing symptoms of bipolar disorder from those that may be due to other mood disorders.
At Psych Congress 2022, PCN sat down with Dr Julie Carbray, clinical professor at the University of Illinois at Chicago and discussed distinguishing symptoms of bipolar disorder from those that may be due to other mood disorders.
At Psych Congress 2022, PCN sat...
09/26/2022
Psych Congress Network
News
Extended-Release Viloxazine and Caffeine Combined Together May Raise Insomnia Risk
09/20/2022
Caffeine use combined with extended-release viloxazine appeared to increase the likelihood of insomnia but no other caffeine-related adverse events in adults with ADHD, according to a poster presentation on September 18th at Psych Congress in...
Caffeine use combined with extended-release viloxazine appeared to increase the likelihood of insomnia but no other caffeine-related adverse events in adults with ADHD, according to a poster presentation on September 18th at Psych Congress in...
Caffeine use combined with...
09/20/2022
Psych Congress Network
Andrew D. Penn.
Q&As
Demystifying Psychedelic-Assisted Therapies With Andrew Penn, MS, PMHNP
09/20/2022
Psych Congress Co-Chair Andrew Penn, MS, PMHNP, talks about the therapeutic potential of psychedelic-assisted psychotherapy and the implications for mental healthcare.
Psych Congress Co-Chair Andrew Penn, MS, PMHNP, talks about the therapeutic potential of psychedelic-assisted psychotherapy and the implications for mental healthcare.
Psych Congress Co-Chair Andrew...
09/20/2022
Psych Congress Network
News
Cariprazine Effective Against ADT-resistant MDD
09/20/2022
Cariprazine could be effective in treating patients with major depressive disorder and inadequate response to antidepressant treatment.
Cariprazine could be effective in treating patients with major depressive disorder and inadequate response to antidepressant treatment.
Cariprazine could be effective...
09/20/2022
Psych Congress Network
News
Top Executives Share Message of Unification and Urgency With Psych Congress Attendees
09/19/2022
CEO Alliance for Mental Health members presented a message of unification, urgency, and equity.
CEO Alliance for Mental Health members presented a message of unification, urgency, and equity.
CEO Alliance for Mental Health...
09/19/2022
Psych Congress Network
News
Lumateperone Improves Symptoms in Patients with Bipolar Depression
09/19/2022
In a phase 3 trial, lumateperone significantly improved depression in patients with bipolar I or II disorder.
In a phase 3 trial, lumateperone significantly improved depression in patients with bipolar I or II disorder.
In a phase 3 trial, lumateperone...
09/19/2022
Psych Congress Network
News
Added Brexpiprazole Improves Life Engagement in Adults With Major Depression
09/18/2022
Adjunctive brexpiprazole was associated with significant gains in patient life engagement in adults with major depressive disorder (MDD) and inadequate response to antidepressant treatment, according to a poster presented at Psych Congress.
Adjunctive brexpiprazole was associated with significant gains in patient life engagement in adults with major depressive disorder (MDD) and inadequate response to antidepressant treatment, according to a poster presented at Psych Congress.
Adjunctive brexpiprazole was...
09/18/2022
Psych Congress Network
News
Zuranolone Eases MDD for Majority of Study Participants, Interim Analysis Shows
09/18/2022
An interim analysis of a phase 3, open-label, year-long study evaluating episodic treatment with zuranolone for major depressive disorder found the majority of patients at study exit had minimal or mild depressive symptoms, including those...
An interim analysis of a phase 3, open-label, year-long study evaluating episodic treatment with zuranolone for major depressive disorder found the majority of patients at study exit had minimal or mild depressive symptoms, including those...
An interim analysis of a phase...
09/18/2022
Psych Congress Network
Alana Iglewicz, MD
Q&As
Prioritizing Practical Care When Treating Prologued Grief Disorder
09/17/2022
Over 2 years after the onset of COVID-19, few lives remain untouched by the public health crisis.
Over 2 years after the onset of COVID-19, few lives remain untouched by the public health crisis.
Over 2 years after the onset of...
09/17/2022
Psych Congress Network
debattista
MDD Conference Insights
Emerging Antidepressants: What Clinicians Can Expect
09/17/2022
As more treatment options become available, Dr DeBattista discusses the limitations of many current antidepressants, why these emerging medications are different, and what clinicians can do in the meantime.
As more treatment options become available, Dr DeBattista discusses the limitations of many current antidepressants, why these emerging medications are different, and what clinicians can do in the meantime.
As more treatment options become...
09/17/2022
Psych Congress Network
Dr Rakesh Jain conducts the Me2/ Boston string orchestra.
Conference Coverage
Me2/ Orchestra Adds Artistic Flair to Practical Psychopharmacology at the 35th Annual Psych Congress
09/17/2022
The 35th Annual Psych Congress got off to a moving start with Friday evening’s first-ever Eric C. Arauz Memorial Keynote Address, entitled “Classical Music for Mental Health” and featuring the Me2/ (pronounced “me, too”) Boston string...
The 35th Annual Psych Congress got off to a moving start with Friday evening’s first-ever Eric C. Arauz Memorial Keynote Address, entitled “Classical Music for Mental Health” and featuring the Me2/ (pronounced “me, too”) Boston string...
The 35th Annual Psych...
09/17/2022
Psych Congress Network
Kimberly Allen
Videos
Patient With Bipolar Disorder Discusses Medication Adherence, Isolation, and Hope
09/14/2022
Kimberly Allen, MS, LCDC, a woman living with bipolar disorder, continues to share her patient perspective.
Kimberly Allen, MS, LCDC, a woman living with bipolar disorder, continues to share her patient perspective.
Kimberly Allen, MS, LCDC, a...
09/14/2022
Psych Congress Network
agronin
Videos
What to Expect at the Geriatric Psychiatry Pre-Conference Program at Psych Congress 2022, With Marc Agronin, MD
09/09/2022
In this exclusive preview video, Section Editor Marc Agronin, MD, shares what he is most looking forward to during the Geriatric Psychiatry Pre-Conference Program at Psych Congress 2022.
In this exclusive preview video, Section Editor Marc Agronin, MD, shares what he is most looking forward to during the Geriatric Psychiatry Pre-Conference Program at Psych Congress 2022.
In this exclusive preview video,...
09/09/2022
Psych Congress Network
Kimberly Allen
Videos
Candid Conversations Key in Bipolar Management, Patient and Advocate Says
09/08/2022
Kimberly Allen, MS, LCDC, shares her experiences as a patient living with bipolar disorder.
Kimberly Allen, MS, LCDC, shares her experiences as a patient living with bipolar disorder.
Kimberly Allen, MS, LCDC, shares...
09/08/2022
Psych Congress Network
Andrew Penn, MS, PMHNP, and Arwen Podesta, MD.
Videos
Clinical Pearls in the Crescent City: Psych Congress 2022 Preview With Andrew Penn, MS, PMHNP, and Arwen Podesta, MD
09/08/2022
Steering Committee Co-Chairs Andrew Penn, MS, PMHNP, and Arwen Podesta, MD, share what they're looking forward to during the 35th Annual Psych Congress meeting. 
Steering Committee Co-Chairs Andrew Penn, MS, PMHNP, and Arwen Podesta, MD, share what they're looking forward to during the 35th Annual Psych Congress meeting. 
Steering Committee Co-Chairs...
09/08/2022
Psych Congress Network
Amber Hoberg, NP and Edward Kaftarian, MD
Videos
Telehealth Offers Flexibility, But Clinicians Should Verify Patient’s Location Before Treatment
03/14/2022
Telehealth reduces barriers to accessing mental health treatment, but clinicians should use caution when treating patients remotely to ensure the patient isn’t across state lines, said Amber Hoberg, NP.
Telehealth reduces barriers to accessing mental health treatment, but clinicians should use caution when treating patients remotely to ensure the patient isn’t across state lines, said Amber Hoberg, NP.
Telehealth reduces barriers to...
03/14/2022
Psych Congress Network
edward kaftarian and amber hoberg
Videos
With Appropriate Vigilance, Telepsychiatry Offers Ecological Validity
02/09/2022
Amber Hoberg, NP, and Edward Kaftarian, MD, explore what clinicians can learn about their patients during telepsychiatry visits while ensuring confidentiality and adequate privacy.
Amber Hoberg, NP, and Edward Kaftarian, MD, explore what clinicians can learn about their patients during telepsychiatry visits while ensuring confidentiality and adequate privacy.
Amber Hoberg, NP, and Edward...
02/09/2022
Psych Congress Network
Andrew Penn and Heather Flint
Video
Discussing Resources in the Field of Psychedelics
02/04/2022
In this video, Psych Congress Steering Committee Member Andrew Penn, MS, PMHNP shares resources and education opportunities for clinicians interested in psychedelic treatments to build a foundation with Heather Flint, senior digital managing...
In this video, Psych Congress Steering Committee Member Andrew Penn, MS, PMHNP shares resources and education opportunities for clinicians interested in psychedelic treatments to build a foundation with Heather Flint, senior digital managing...
In this video, Psych Congress...
02/04/2022
Psych Congress Network
Andrew Penn and Heather Flint
Video
The Implementation of Psychedelic Treatment
02/04/2022
In this video, Psych Congress Steering Committee Member Andrew Penn, MS, PMHNP shares advice for clinicians interested in psychedelic treatments with Heather Flint, senior digital managing editor, Psych Congress Network.
In this video, Psych Congress Steering Committee Member Andrew Penn, MS, PMHNP shares advice for clinicians interested in psychedelic treatments with Heather Flint, senior digital managing editor, Psych Congress Network.
In this video, Psych Congress...
02/04/2022
Psych Congress Network
Videos
Ketamine-Assisted Therapy for Treatment-Resistant Mental Health Disorders
02/04/2022
In this video, Heather Flint, senior digital managing editor, Psych Congress Network, talks with Psych Congress Steering Committee Member Andrew Penn, MS, PMHNP about ketamine-assisted therapy for treatment-resistant mental health disorders.
In this video, Heather Flint, senior digital managing editor, Psych Congress Network, talks with Psych Congress Steering Committee Member Andrew Penn, MS, PMHNP about ketamine-assisted therapy for treatment-resistant mental health disorders.
In this video, Heather Flint,...
02/04/2022
Psych Congress Network
Videos
Discussing the History of Psychedelic Therapy
02/03/2022
Psych Congress Steering Committee Member Andrew Penn, MS, PMHNP, discusses the history of psychedelic treatments and psychedelic treatment for treatment-resistant mental health disorders.
Psych Congress Steering Committee Member Andrew Penn, MS, PMHNP, discusses the history of psychedelic treatments and psychedelic treatment for treatment-resistant mental health disorders.
Psych Congress Steering...
02/03/2022
Psych Congress Network
News
Underrepresentation in Psychedelic Studies May Indicate Findings Cannot be Generalized
02/03/2022
Results from psychedelic medicine studies may not translate across ethnic groups as minorities are highly underrepresented in studies on the subject, according to a methodological search review published in BMC Psychiatry.
Results from psychedelic medicine studies may not translate across ethnic groups as minorities are highly underrepresented in studies on the subject, according to a methodological search review published in BMC Psychiatry.
Results from psychedelic...
02/03/2022
Psych Congress Network
Laptop computer
Videos
Dr Medrano Shares Resources to Learn More About Psychedelics
02/03/2022
Michael J Verbora, MD, MBA, asks Ben Medrano, MD, to share educational resources such as training, conferences, and institutions for clinicians seeking to learn more about getting involved with psychedelic treatment options.
Michael J Verbora, MD, MBA, asks Ben Medrano, MD, to share educational resources such as training, conferences, and institutions for clinicians seeking to learn more about getting involved with psychedelic treatment options.
Michael J Verbora, MD, MBA, asks...
02/03/2022
Psych Congress Network
cannabis
Videos
The Future of Psychedelics and Lessons Learned From the Cannabis Industry
02/03/2022
Michael J Verbora, MD, MBA, and Ben Medrano, MD, discuss whether psychedelics will be used in a nonmedical context, future research, and lessons learned from the cannabis industry including it being an alternative to opiates.
Michael J Verbora, MD, MBA, and Ben Medrano, MD, discuss whether psychedelics will be used in a nonmedical context, future research, and lessons learned from the cannabis industry including it being an alternative to opiates.
Michael J Verbora, MD, MBA, and...
02/03/2022
Psych Congress Network
trauma depression anxiety
Videos
Implementing the Ketamine-Assisted Psychotherapy Approach
02/03/2022
Michael J Verbora, MD, MBA, asks Ben Medrano, MD to explain ketamine-assisted psychotherapy [KAP] implementation and the experiences patients have had with the treatment.
Michael J Verbora, MD, MBA, asks Ben Medrano, MD to explain ketamine-assisted psychotherapy [KAP] implementation and the experiences patients have had with the treatment.
Michael J Verbora, MD, MBA, asks...
02/03/2022
Psych Congress Network
bipolar graphic
Videos
More Evidence Needed for IV Ketamine Treatment in Personality Disorders
02/03/2022
Ben Medrano, MD, and Michael J Verbora, MD, MBA discuss what patient populations are benefiting most from intravenous (IV) ketamine treatment and what populations could be potentially harmed by the treatment.
Ben Medrano, MD, and Michael J Verbora, MD, MBA discuss what patient populations are benefiting most from intravenous (IV) ketamine treatment and what populations could be potentially harmed by the treatment.
Ben Medrano, MD, and Michael J...
02/03/2022
Psych Congress Network
Samantha Lau
Videos
Unpacking Women’s Mental Health Care and Trauma-Informed Psychotherapy
02/01/2022
Samantha Lau, MSN, FNP-BC, PMHNP-BC, discusses trauma-informed psychotherapy and how it “impacts someone's mental health, physical health, and relationships.”
Samantha Lau, MSN, FNP-BC, PMHNP-BC, discusses trauma-informed psychotherapy and how it “impacts someone's mental health, physical health, and relationships.”
Samantha Lau, MSN, FNP-BC,...
02/01/2022
Psych Congress Network
IV ketamine
Videos
The Biomedical Model vs Psychedelic Model in IV Ketamine Treatment
02/01/2022
Ben Medrano, MD, and Michael J Verbora, MD, MBA, discuss the pros and cons of the biomedical model and the psychedelic model in IV ketamine treatment and the KAP approach.
Ben Medrano, MD, and Michael J Verbora, MD, MBA, discuss the pros and cons of the biomedical model and the psychedelic model in IV ketamine treatment and the KAP approach.
Ben Medrano, MD, and Michael J...
02/01/2022
Psych Congress Network
Dr Edward Kaftarian
Videos
Market Forces Are Driving Telehealth Advancements
01/26/2022
Edward Kaftarian, MD, describes the advances in medical records as a shareable resource and how market forces are driving telehealth.
Edward Kaftarian, MD, describes the advances in medical records as a shareable resource and how market forces are driving telehealth.
Edward Kaftarian, MD, describes...
01/26/2022
Psych Congress Network
Edward Kaftarian
Videos
Telehealth is “Here to Stay,” Says Dr Edward Kaftarian
01/13/2022
In part 2 of this video, Edward Kaftarian, MD, explores why telehealth is “here to stay” and why he hopes government officials will continue to have an open policy about telehealth.
In part 2 of this video, Edward Kaftarian, MD, explores why telehealth is “here to stay” and why he hopes government officials will continue to have an open policy about telehealth.
In part 2 of this video, Edward...
01/13/2022
Psych Congress Network
Craig Bryan, PsyD, ABPP
Videos
Creating a Crisis Response Plan for Patients With Suicidal Ideation and Trauma-Related Disorders
01/12/2022
Craig Bryan, PsyD, ABPP discusses creating a tailored crisis response plan that helps patients feel more in control of their mental health as well as building a positive clinician-patient relationship.
Craig Bryan, PsyD, ABPP discusses creating a tailored crisis response plan that helps patients feel more in control of their mental health as well as building a positive clinician-patient relationship.
Craig Bryan, PsyD, ABPP...
01/12/2022
Psych Congress Network
Edward Kaftarian
Videos
Telepsychiatry Reduces Barriers and Increases Mental Health Care Access
01/10/2022
Edward Kaftarian, MD, discusses the impact telepsychiatry has had on access to mental healthcare, including removing barriers, and whether or not specific mental health disorders are contraindicated with the medium.
Edward Kaftarian, MD, discusses the impact telepsychiatry has had on access to mental healthcare, including removing barriers, and whether or not specific mental health disorders are contraindicated with the medium.
Edward Kaftarian, MD, discusses...
01/10/2022
Psych Congress Network
Craig Bryan, PsyD, ABPP
Videos
PTSD Comorbid Conditions and Suicidal Ideation Interventions
01/06/2022
Craig Bryan, PsyD, ABPP, explores clinical signs that help diagnose a patient with post-traumatic stress disorder (PTSD), the common comorbid conditions, and suicidal indications.
Craig Bryan, PsyD, ABPP, explores clinical signs that help diagnose a patient with post-traumatic stress disorder (PTSD), the common comorbid conditions, and suicidal indications.
Craig Bryan, PsyD, ABPP,...
01/06/2022
Psych Congress Network
Lindsay Galvin Rauch
Videos
Education for Clinicians, Family, and Law Enforcement is Key in Better Treatment of Schizophrenia, Says Advocate
12/20/2021
Sibling of 6 brothers diagnosed with schizophrenia, says clinicians, families, and law enforcement could benefit from education about the disorder, specifically the comorbid condition of anosognosia.
Sibling of 6 brothers diagnosed with schizophrenia, says clinicians, families, and law enforcement could benefit from education about the disorder, specifically the comorbid condition of anosognosia.
Sibling of 6 brothers diagnosed...
12/20/2021
Psych Congress Network
Lindsay Galvin Rauch
Videos
Anosognosia Education Could Help Clinicians Treat Schizophrenia More Effectively
12/15/2021
Anosognosia affects a large percentage of patients with schizophrenia and knowledge of it can help clinicians and caretakers better treat patients, says Linsday Galvin Rauch in part 5 of this series.
Anosognosia affects a large percentage of patients with schizophrenia and knowledge of it can help clinicians and caretakers better treat patients, says Linsday Galvin Rauch in part 5 of this series.
Anosognosia affects a large...
12/15/2021
Psych Congress Network
James A Jenkins
Videos
Correctly Diagnosing Personality Disorders and Bipolar Disorder Comorbidities
12/14/2021
James A. Jenkins, MD, discusses resources for clinicians to correctly diagnose comorbidities of personality disorders, such as bipolar disorder, and explores the impact of substance use disorders.
James A. Jenkins, MD, discusses resources for clinicians to correctly diagnose comorbidities of personality disorders, such as bipolar disorder, and explores the impact of substance use disorders.
James A. Jenkins, MD,...
12/14/2021
Psych Congress Network
Lindsay Galvin Rauch
Videos
Patients With Schizophrenia Face Discrimination From Clinicians, Says Sibling of Brothers With the Condition
12/14/2021
In part 4 of this series, Lindsay Galvin Rauch describes the challenges her brothers with schizophrenia experienced when admitted to the ER and the advocacy required as their sibling and caretaker.
In part 4 of this series, Lindsay Galvin Rauch describes the challenges her brothers with schizophrenia experienced when admitted to the ER and the advocacy required as their sibling and caretaker.
In part 4 of this series,...
12/14/2021
Psych Congress Network
Jenkins
Videos
Effects of Comorbid BPD and MDD on Personality Disorders
12/08/2021
Comorbid bipolar disorder or major depressive disorder is high risk and affects personality disorder treatment, says James A. Jenkins, MD.
Comorbid bipolar disorder or major depressive disorder is high risk and affects personality disorder treatment, says James A. Jenkins, MD.
Comorbid bipolar disorder or...
12/08/2021
Psych Congress Network
Lindsay Galvin Rauch
Videos
Genetic Research Offers Hope to Family With 6 Siblings Diagnosed With Schizophrenia
12/08/2021
Lindsay Galvin Rauch explains the impact research had on her family’s journey and discusses the overall opinion the public has on people living with schizophrenia.
Lindsay Galvin Rauch explains the impact research had on her family’s journey and discusses the overall opinion the public has on people living with schizophrenia.
Lindsay Galvin Rauch explains...
12/08/2021
Psych Congress Network
News
Valbenazine Use for Tardive Dyskinesia in Older Adults Proves Efficacious
12/08/2021
Valbenazine use for tardive dyskinesia (TD) in adults aged 65 and older has been deemed efficacious with comparable outcomes to younger adults, according to a post hoc analysis.
Valbenazine use for tardive dyskinesia (TD) in adults aged 65 and older has been deemed efficacious with comparable outcomes to younger adults, according to a post hoc analysis.
Valbenazine use for tardive...
12/08/2021
Psych Congress Network
Manpreet Singh
Videos
Dr Singh Offers "Clinical Clues" to Distinguish Pediatric ADHD From Mood Disorders
12/07/2021
Manpreet K Singh, MD, MS, offers "clinical clues" to clinicians on how to distinguish ADHD from primary mood disorders or other conditions and also discusses comorbid conditions in pediatric ADHD. 
Manpreet K Singh, MD, MS, offers "clinical clues" to clinicians on how to distinguish ADHD from primary mood disorders or other conditions and also discusses comorbid conditions in pediatric ADHD. 
Manpreet K Singh, MD, MS, offers...
12/07/2021
Psych Congress Network
Arwen Podesta, MD, ABPN, FASAM, ABIHM
Videos
Opioid Prescribing Best Practices: Warning Signs, Tapering Strategies, and Alternatives
12/07/2021
Arwen Podesta, MD, ABPN, FASAM, ABIHM, a New Orleans-based psychiatrist, shares tips and strategies for identifying potential opioid misuse by patients, how to craft a tapering strategy, and alternative interventions for patients at a...
Arwen Podesta, MD, ABPN, FASAM, ABIHM, a New Orleans-based psychiatrist, shares tips and strategies for identifying potential opioid misuse by patients, how to craft a tapering strategy, and alternative interventions for patients at a...
Arwen Podesta, MD, ABPN, FASAM,...
12/07/2021
Psych Congress Network
Lindsay Galvin
Videos
Family Impacts Awareness and Research of Schizophrenia While Living With the Condition at Home
12/06/2021
In part 2 of this 6-part video series, Lindsay Galvin Rauch explored how her family was able to impact schizophrenia research the awareness of the condition.
In part 2 of this 6-part video series, Lindsay Galvin Rauch explored how her family was able to impact schizophrenia research the awareness of the condition.
In part 2 of this 6-part video...
12/06/2021
Psych Congress Network
Dr Jenkins Psych Congress Emerson
Videos
Bipolar Disorder Often Diagnosed Without Evidence in Patients With NPD and BPD
12/03/2021
James A. Jenkins, MD discusses the differences between NPD and BPD and how these 2 disorders often get misdiagnosed as bipolar disorder despite a lack of evidence to support the diagnosis.
James A. Jenkins, MD discusses the differences between NPD and BPD and how these 2 disorders often get misdiagnosed as bipolar disorder despite a lack of evidence to support the diagnosis.
James A. Jenkins, MD discusses...
12/03/2021
Psych Congress Network
Greg Mattingly, MD
Podcasts
Managing Pediatric ADHD and Stress During the Holidays
12/03/2021
Greg Mattingly, MD, shares tips and advice on managing pediatric ADHD and stress through the holiday season.
Greg Mattingly, MD, shares tips and advice on managing pediatric ADHD and stress through the holiday season.
Greg Mattingly, MD, shares tips...
12/03/2021
Psych Congress Network
Lindsay Galvin
Videos
Sibling of Brothers With Schizophrenia Finds Hope Through Therapy and Connectedness
12/02/2021

In part 1 of this 6 part video series, Lindsay Galvin Rauch shares her background of growing up in a family with schizophrenia and how Galvin Rauch came to find therapy as a healing resource for her trauma.
In part 1 of this 6 part video series, Lindsay Galvin Rauch shares her background of growing up in a family with schizophrenia and how Galvin Rauch came to find therapy as a healing resource for her trauma.
In part 1 of this 6 part video...
12/02/2021
Psych Congress Network
Jain
Podcasts
Tardive Dyskinesia, Comorbidities and Treatment Options
12/02/2021
Rakesh Jain, MD, MPH, guides a Q&A session with Rajeev Kumar, MD, and Jonathan M Meyer, MD, on their Psych Congress session titled "Tardive Dyskinesia Across the Complexity Spectrum – From Quality of Life Improvement to Novel Treatments."
Rakesh Jain, MD, MPH, guides a Q&A session with Rajeev Kumar, MD, and Jonathan M Meyer, MD, on their Psych Congress session titled "Tardive Dyskinesia Across the Complexity Spectrum – From Quality of Life Improvement to Novel Treatments."
Rakesh Jain, MD, MPH, guides a...
12/02/2021
Psych Congress Network
Manpreet Singh
Videos
Treatment of ADHD Throughout the Holiday Season
11/22/2021
Manpreet K Singh, MD, MS, director, offers tips for clinicians to maintain manage expectations and the best possible care for patients with ADHD throughout the holiday season.
Manpreet K Singh, MD, MS, director, offers tips for clinicians to maintain manage expectations and the best possible care for patients with ADHD throughout the holiday season.
Manpreet K Singh, MD, MS,...
11/22/2021
Psych Congress Network
Craig Chepke
Videos
Tailored Treatment Plans and Challenges for Bipolar Disorder
11/17/2021
Craig Chepke, MD, FAPA, addresses tailoring treatment plans and offers his insights on the biggest challenges for other clinicians when treating patients with bipolar disorder.
Craig Chepke, MD, FAPA, addresses tailoring treatment plans and offers his insights on the biggest challenges for other clinicians when treating patients with bipolar disorder.
Craig Chepke, MD, FAPA,...
11/17/2021
Psych Congress Network
Amber Hoberg
Videos
Family Intervention, Crisis Response Plan for Patients With Schizophrenia
11/17/2021
Amber Hoberg, NP, discusses family intervention and crisis response plans for treating patients with schizophrenia.
Amber Hoberg, NP, discusses family intervention and crisis response plans for treating patients with schizophrenia.
Amber Hoberg, NP, discusses...
11/17/2021
Psych Congress Network
Hoberg and Thistle
Videos
Schizophrenia Treatment, Medication Adherence and Collaborative Care
11/17/2021
Amber Hoberg, NP, discusses medication adherence and collaborative care for patients with schizophrenia.
Amber Hoberg, NP, discusses medication adherence and collaborative care for patients with schizophrenia.
Amber Hoberg, NP, discusses...
11/17/2021
Psych Congress Network
News
Individual Titration of Deutetrabenazine Beneficial for Patients With Tardive Dyskinesia
11/17/2021
Response-driven titration of deutetrabenazine is beneficial for patients with tardive dyskinesia (TD), according to new findings.
Response-driven titration of deutetrabenazine is beneficial for patients with tardive dyskinesia (TD), according to new findings.
Response-driven titration of...
11/17/2021
Psych Congress Network
Amber Hoberg
Videos
Meeting Patients With Schizophrenia 'Where They Are'
11/17/2021
Amber Hoberg, NP, discusses meeting her patient with schizophrenia where they are to provide treatment and therapy.
Amber Hoberg, NP, discusses meeting her patient with schizophrenia where they are to provide treatment and therapy.
Amber Hoberg, NP, discusses...
11/17/2021
Psych Congress Network
Dr Chan and Dr Jain
Podcasts
Digital Mental Health Reduces Barriers and is ‘Not Going Anywhere’
11/16/2021
Steven R Chan, MD, MBA, and Gowri Aragam, MD, discuss the barriers and challenges when implementing digital mental health (DMH) into clinical practice and the future of telehealth.
Steven R Chan, MD, MBA, and Gowri Aragam, MD, discuss the barriers and challenges when implementing digital mental health (DMH) into clinical practice and the future of telehealth.
Steven R Chan, MD, MBA, and...
11/16/2021
Psych Congress Network
Rajeev Kumar MD
Videos
Importance of Identifying, Treating, and Reassessing Tardive Dyskinesia Symptoms
11/15/2021
Clinicians should screen for tardive dyskinesia and "assess the impact on the individual" if it is identified, says Rajeev Kumar, MD. He also discusses other key takeaways from his Psych Congress session.
Clinicians should screen for tardive dyskinesia and "assess the impact on the individual" if it is identified, says Rajeev Kumar, MD. He also discusses other key takeaways from his Psych Congress session.
Clinicians should screen...
11/15/2021
Psych Congress Network
News
Tardive Dyskinesia Creates Physical, Psychological, and Social Burden
11/12/2021
Tardive dyskinesia negatively impacts patients’ physical functioning, mental well-being, and social activities—even in patients with self-assessed mild-to-moderate symptoms.
Tardive dyskinesia negatively impacts patients’ physical functioning, mental well-being, and social activities—even in patients with self-assessed mild-to-moderate symptoms.
Tardive dyskinesia negatively...
11/12/2021
Psych Congress Network
yashi brown psych congress
Videos
Mindfulness, Nutrition, and Other Tools to Manage Bipolar Symptoms
11/10/2021
Psych Congress keynote speaker, Yashi Brown, spoken word poet and mental health advocate, discusses the ways she practices mindfulness, nutrition, other tools to better manage her bipolar symptoms.
Psych Congress keynote speaker, Yashi Brown, spoken word poet and mental health advocate, discusses the ways she practices mindfulness, nutrition, other tools to better manage her bipolar symptoms.
Psych Congress keynote speaker,...
11/10/2021
Psych Congress Network
Chan and Aragam
Podcasts
Digital Mental Health Encompasses More Than Telehealth
11/10/2021
Steven R Chan, MD, MBA, and Gowri Aragam, MD, sat down at the recent 2021 Psych Congress to discuss the current and future landscape of digital mental health (DMH).
Steven R Chan, MD, MBA, and Gowri Aragam, MD, sat down at the recent 2021 Psych Congress to discuss the current and future landscape of digital mental health (DMH).
Steven R Chan, MD, MBA,...
11/10/2021
Psych Congress Network
Rajeev Kumar MD
Videos
Overtreatment of Tardive Dyskinesia May Cause More Side Effects
11/08/2021
It is possible to overtreat tardive dyskinesia (TD) which can lead to other issues; clinicians should manage and reduce symptoms to improve quality of life, says Dr Rajeev Kumar.
It is possible to overtreat tardive dyskinesia (TD) which can lead to other issues; clinicians should manage and reduce symptoms to improve quality of life, says Dr Rajeev Kumar.
It is possible to overtreat...
11/08/2021
Psych Congress Network
Greg Mattingly, MD
Videos
Pediatric ADHD: Hot Topics From Psych Congress
11/05/2021
Greg Mattingly, MD, discusses the “hot topics” in pediatric attention-deficient/hyperactivity disorder (ADHD) that were presented at the recent Psych Congress in San Antonio.
Greg Mattingly, MD, discusses the “hot topics” in pediatric attention-deficient/hyperactivity disorder (ADHD) that were presented at the recent Psych Congress in San Antonio.
Greg Mattingly, MD, discusses...
11/05/2021
Psych Congress Network
Leslie Citrome, MD
Videos
Schizophrenia Therapies: All Roads Lead to Dopamine
11/05/2021
Leslie Citrome, MD, MPH, discusses new treatments for patients with schizophrenia, including the TAAR1 agonist currently in phase 3 clinical trials.
Leslie Citrome, MD, MPH, discusses new treatments for patients with schizophrenia, including the TAAR1 agonist currently in phase 3 clinical trials.
Leslie Citrome, MD, MPH,...
11/05/2021
Psych Congress Network
Yashi Brown
Videos
Personal Experiences With Bipolar Depression
11/04/2021
Yashi Brown sat down at the recent Psych Congress to dive deeper into her keynote address titled, "Discovering the sweet spot: how bipolar disorder became a blessing... not a curse."
Yashi Brown sat down at the recent Psych Congress to dive deeper into her keynote address titled, "Discovering the sweet spot: how bipolar disorder became a blessing... not a curse."
Yashi Brown sat down at the...
11/04/2021
Psych Congress Network
mattingly
Videos
Geriatric ADHD Discussed at Psych Congress 2021
11/04/2021
Greg Mattingly, MD, recaps ADHD "hot topics" discussed at Psych Congress 2021 and reminds clinicians to be mindful that treating the disorder changes with age.
Greg Mattingly, MD, recaps ADHD "hot topics" discussed at Psych Congress 2021 and reminds clinicians to be mindful that treating the disorder changes with age.
Greg Mattingly, MD, recaps ADHD...
11/04/2021
Psych Congress Network
Dr Parthasarathy
Association of EDS, PAP, and Quality of Care With OSA
11/04/2021
In this Q&A, Sairam Parthasarathy, MD, the association of excessive daytime sleepiness, positive airway pressure adherence, and satisfaction with care related to obstructive sleep apnea.
In this Q&A, Sairam Parthasarathy, MD, the association of excessive daytime sleepiness, positive airway pressure adherence, and satisfaction with care related to obstructive sleep apnea.
In this Q&A, Sairam...
11/04/2021
Psych Congress Network
wilens
Q&As
Misconceptions, Treatment of Adult ADHD
11/04/2021
Timothy E. Wilens, MD, answers questions about his Psych Congress 2021 session titled “What’s New in Adult and Pediatric ADHD: A 2021 Psychopharmacology Update” that focus on adult ADHD.
Timothy E. Wilens, MD, answers questions about his Psych Congress 2021 session titled “What’s New in Adult and Pediatric ADHD: A 2021 Psychopharmacology Update” that focus on adult ADHD.
Timothy E. Wilens, MD, answers...
11/04/2021
Psych Congress Network
Wilens
Q&As
Support, Accommodation May Reduce Pediatric ADHD Severity
11/04/2021
Pediatric attention-deficient/hyperactivity disorder (ADHD) can be “largely reversed” with the proper support, accommodation, and treatment, says Timothy E. Wilens, MD.
Pediatric attention-deficient/hyperactivity disorder (ADHD) can be “largely reversed” with the proper support, accommodation, and treatment, says Timothy E. Wilens, MD.
Pediatric...
11/04/2021
Psych Congress Network
Robert Kolker Hidden Valley Road
Videos
Robert Kolker Talks Impacts of his Novel About a Family Impacted by Schizophrenia
11/03/2021
Robert Kolker, the author of "Hidden Valley Road: Inside the Minds of an American Family," expands on his featured session at the recent Psych Congress meeting.
Robert Kolker, the author of "Hidden Valley Road: Inside the Minds of an American Family," expands on his featured session at the recent Psych Congress meeting.
Robert Kolker, the author of...
11/03/2021
Psych Congress Network
Craig Bryan, PsyD, ABPP
Q&As
Implementing a Suicidal Ideation Crisis Response Plan
11/03/2021
In this Q&A, Craig Bryan, PsyD, ABPP, addressed some additional questions from his recent Psych Congress session, “Helping Your Patient Manage Suicidal Ideation and Behavior: Crisis Response Plan.”
In this Q&A, Craig Bryan, PsyD, ABPP, addressed some additional questions from his recent Psych Congress session, “Helping Your Patient Manage Suicidal Ideation and Behavior: Crisis Response Plan.”
In this Q&A, Craig Bryan, PsyD,...
11/03/2021
Psych Congress Network
Mark Zimmerman, Brown University
Videos
Diagnosing and Treating Borderline Personality Disorder
11/01/2021
Mark Zimmerman, MD, professor of psychiatry and human behavior, Brown University, Providence, Rhode Island, explores key takeaways from his live 2021 Psych Congress session where he discussed the diagnoses and treatment of borderline...
Mark Zimmerman, MD, professor of psychiatry and human behavior, Brown University, Providence, Rhode Island, explores key takeaways from his live 2021 Psych Congress session where he discussed the diagnoses and treatment of borderline...
Mark Zimmerman, MD, professor of...
11/01/2021
Psych Congress Network
Danielle J. Johnson, MD, FAPA
Q&As
COVID-19 Pandemic Increased Racial Disparities in Medical Care
11/01/2021
Danielle J. Johnson, MD, FAPA, answers questions about her session at the 2021 Psych Congress titled "Diversity and Cultural Competence: The Impact of “Dual Pandemics” on Women’s Mental Health".
Danielle J. Johnson, MD, FAPA, answers questions about her session at the 2021 Psych Congress titled "Diversity and Cultural Competence: The Impact of “Dual Pandemics” on Women’s Mental Health".
Danielle J. Johnson, MD, FAPA,...
11/01/2021
Psych Congress Network
Amber Hoberg, NP Centric Physicians Group, San Antonio, Texas
Videos
Improving Medication Adherence in Patients With Schizophrenia
10/31/2021
Amber Hoberg, NP, discusses an additional case study to complement her Psych Congress session, as well as key takeaways, medication non-adherence, and common misconceptions.
Amber Hoberg, NP, discusses an additional case study to complement her Psych Congress session, as well as key takeaways, medication non-adherence, and common misconceptions.
Amber Hoberg, NP, discusses an...
10/31/2021
Psych Congress Network
Lasseter
Q&As
Premenstrual Dysphoric Disorder & Premenstrual Exacerbation: Diagnosis and Treatment
10/30/2021
Kristin Yeung Lasseter, MD presented a session titled “Mood Disorders Related to the Menstrual Cycle” at this weekend’s Psych Congress in San Antonio, Texas.
Kristin Yeung Lasseter, MD presented a session titled “Mood Disorders Related to the Menstrual Cycle” at this weekend’s Psych Congress in San Antonio, Texas.
Kristin Yeung Lasseter, MD...
10/30/2021
Psych Congress Network
News
Positive Airway Pressure Adherence, Patient Satisfaction for OSA Treatment
10/29/2021
There is a relationship between excessive daytime sleepiness (EDS) and positive airway pressure (PAP) adherence for patients with obstructive sleep apnea (OSA), according to recent research.
There is a relationship between excessive daytime sleepiness (EDS) and positive airway pressure (PAP) adherence for patients with obstructive sleep apnea (OSA), according to recent research.
There is a relationship between...
10/29/2021
Psych Congress Network
Schizophrenia
Once-Monthly LAIs May Lower Schizophrenia Hospitalization Rates
10/29/2021
Once-monthly LAIs showed lower rates of hospitalization when compared to daily oral injectables and biweekly LAIs, according to new research shown in a poster presentation at Psych Congress.
Once-monthly LAIs showed lower rates of hospitalization when compared to daily oral injectables and biweekly LAIs, according to new research shown in a poster presentation at Psych Congress.
Once-monthly LAIs showed lower...
10/29/2021
Psych Congress Network
Jay Fawver, MD Parkview Behavioral Health Institute
Q&As
Vortioxetine Significantly Reduces Symptom Severity in Patients With MDD
10/29/2021
Jay Fawver, MD, discusses a Psych Congress poster about vortioxetine significantly reducing depression severity in patients with MDD.
Jay Fawver, MD, discusses a Psych Congress poster about vortioxetine significantly reducing depression severity in patients with MDD.
Jay Fawver, MD, discusses a...
10/29/2021
Psych Congress Network
Graham J Emslie MD
Managing Depression in Youth
10/28/2021
Graham J Emslie, MD, answers questions about his 2021 Psych Congress session titled "Comprehensive Approaches for Managing Depression in Youth".
Graham J Emslie, MD, answers questions about his 2021 Psych Congress session titled "Comprehensive Approaches for Managing Depression in Youth".
Graham J Emslie, MD, answers...
10/28/2021
Psych Congress Network
The Therapy Players
Comedy Improv and Mental Health
10/28/2021
In this Q&A, The Therapy Players give a teaser of what to expect at their upcoming Psych Congress session and share their insights on how comedy can be a useful tool in psychotherapy.
In this Q&A, The Therapy Players give a teaser of what to expect at their upcoming Psych Congress session and share their insights on how comedy can be a useful tool in psychotherapy.
In this Q&A, The Therapy Players...
10/28/2021
Psych Congress Network
Charles Raison Psych Congress
Videos
Psych Congress 2021: What to Expect With Dr Raison
10/27/2021
Psych Congress 2021 Co-Chair, Charles Raison, MD, welcomes attendees and shares some upcoming highlights of the conference.
Psych Congress 2021 Co-Chair, Charles Raison, MD, welcomes attendees and shares some upcoming highlights of the conference.
Psych Congress 2021 Co-Chair,...
10/27/2021
Psych Congress Network
Julie Carbray
Blog
Julie Carbray Welcomes You to Psych Congress
10/25/2021
A welcome message from Co-chair, Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, for the 2021 Psych Congress annual meeting in San Antonio, TX.
A welcome message from Co-chair, Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, for the 2021 Psych Congress annual meeting in San Antonio, TX.
A welcome message from Co-chair,...
10/25/2021
Psych Congress Network
Dr Julie Carbray
Updates in Child and Adolescent Psychiatry
10/20/2021
In this video, Psych Congress 2021 co-chair Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, Clinical Professor of Psychiatry and Nursing, University of Illinois at Chicago; Administrative Director, Pediatric Mood Disorder Clinic, Pediatric...
In this video, Psych Congress 2021 co-chair Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, Clinical Professor of Psychiatry and Nursing, University of Illinois at Chicago; Administrative Director, Pediatric Mood Disorder Clinic, Pediatric...
In this video, Psych Congress...
10/20/2021
Psych Congress Network
Michael Grandner
Q&A
Excessive Daytime Sleepiness Effects on Mental Health and Wellness
10/19/2021
Michael Grandner discusses his upcoming poster presentation at Psych Congress and answers questions related to the effects of daytime sleepiness on mental health.
Michael Grandner discusses his upcoming poster presentation at Psych Congress and answers questions related to the effects of daytime sleepiness on mental health.
Michael Grandner discusses his...
10/19/2021
Psych Congress Network
Understanding the New TD Treatment Guidelines
Videos
Understanding the New TD Treatment Guidelines
04/22/2021
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses recent guidelines on identifying and treating tardive dyskinesia.
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses recent guidelines on identifying and treating tardive dyskinesia.
Psych Congress Steering...
04/22/2021
Psych Congress Network
Late-Onset ADHD: Recent Research and Remaining Questions
Videos
Late-Onset ADHD: Recent Research and Remaining Questions
03/26/2021
ADHD Section Editor and Psych Congress Steering Committee member Vladimir Maletic, MD, MS, discusses recent research developments regarding late-onset ADHD and questions that remain unanswered.
ADHD Section Editor and Psych Congress Steering Committee member Vladimir Maletic, MD, MS, discusses recent research developments regarding late-onset ADHD and questions that remain unanswered.
ADHD Section Editor...
03/26/2021
Psych Congress Network
The Effects of Psychiatric Comorbidities in People With ADHD
Videos
The Effects of Psychiatric Comorbidities in People With ADHD
03/09/2021
In this video, Psych Congress Steering Committee member Vladimir Maletic, MD, MS, answers the question "How do psychiatric comorbidities affect the mortality risk of people with ADHD?"
In this video, Psych Congress Steering Committee member Vladimir Maletic, MD, MS, answers the question "How do psychiatric comorbidities affect the mortality risk of people with ADHD?"
In this video, Psych...
03/09/2021
Psych Congress Network
Dr Vladimir Maletic on Defining and Responding to Complex ADHD
Videos
Dr Vladimir Maletic on Defining and Responding to Complex ADHD
03/01/2021
In this video, Psych Congress Steering Committee member Vladimir Maletic, MD, MS, discusses the concept of complex attention/deficit-hyperactivity disorder, how it is defined, and how to respond to it.
In this video, Psych Congress Steering Committee member Vladimir Maletic, MD, MS, discusses the concept of complex attention/deficit-hyperactivity disorder, how it is defined, and how to respond to it.
In this video, Psych Congress...
03/01/2021
Psych Congress Network
Recent Developments in Genetic Studies Examining ADHD
Videos
Recent Developments in Genetic Studies Examining ADHD
02/22/2021
Psych Congress Steering Committee member Vladimir Maletic, MD, MS, summarizes some recent findings related to genome‑wide association studies examining attention/deficit-hyperactivity disorder (ADHD).
Psych Congress Steering Committee member Vladimir Maletic, MD, MS, summarizes some recent findings related to genome‑wide association studies examining attention/deficit-hyperactivity disorder (ADHD).
Psych Congress Steering...
02/22/2021
Psych Congress Network
The Relevance of Noncore Symptoms in Patients With ADHD
Videos
The Relevance of Noncore Symptoms in Patients With ADHD
02/16/2021
In this video, Psych Congress Steering Committee member Vladimir Maletic, MD, MS, discusses the noncore symptoms of attention/deficit-hyperactivity disorder (ADHD) and how they are relevant to diagnosis and treatment.
In this video, Psych Congress Steering Committee member Vladimir Maletic, MD, MS, discusses the noncore symptoms of attention/deficit-hyperactivity disorder (ADHD) and how they are relevant to diagnosis and treatment.
In this video, Psych Congress...
02/16/2021
Psych Congress Network
Strategies for Treating Patients With Both ADHD and SUD
Videos
Strategies for Treating Patients With Both ADHD and SUD
10/06/2020
In this video, Psych Congress 2020 presenter Timothy Wilens, MD, provides strategies clinicians can use when treating a patient with both attention-deficit/hyperactivity disorder (ADHD) and substance use disorder (SUD).
In this video, Psych Congress 2020 presenter Timothy Wilens, MD, provides strategies clinicians can use when treating a patient with both attention-deficit/hyperactivity disorder (ADHD) and substance use disorder (SUD).
In this video, Psych Congress...
10/06/2020
Psych Congress Network
Deutetrabenazine Effective for TD Across Age Groups
Videos
Deutetrabenazine Effective for TD Across Age Groups
10/05/2020
Martha Sajatovic, MD, provides details of a study which found that deutetrabenazine was effective as a treatment for tardive dyskinesia both in patients aged less than 55 years and in patients aged 55 years or older.
Martha Sajatovic, MD, provides details of a study which found that deutetrabenazine was effective as a treatment for tardive dyskinesia both in patients aged less than 55 years and in patients aged 55 years or older.
Martha Sajatovic, MD, provides...
10/05/2020
Psych Congress Network
News
Deutetrabenazine Offers Long-Term Benefit for Severe TD
10/01/2020
Deutetrabenazine offers long-term benefit for patients with severe tardive dyskinesia (TD), according to results from a 3-year open-label extension trial presented in a poster at Psych Congress 2020.
Deutetrabenazine offers long-term benefit for patients with severe tardive dyskinesia (TD), according to results from a 3-year open-label extension trial presented in a poster at Psych Congress 2020.
Deutetrabenazine offers...
10/01/2020
Psychiatry & Behavioral Health
News
Adverse Events With Deutetrabenazine Titration Decrease During Maintenance
10/01/2020
Adverse events in patients treated with deutetrabenazine were more common during titration than maintenance, a finding that provides “important context for the dosing schedule to providers and patients.”
Adverse events in patients treated with deutetrabenazine were more common during titration than maintenance, a finding that provides “important context for the dosing schedule to providers and patients.”
Adverse events in patients...
10/01/2020
Psych Congress Network
News
3-Point Drop in AIMS Score Provides Clinically Meaningful Gains in TD
10/01/2020
A decrease of 3 points on the Abnormal Involuntary Movement Scale score is the minimal clinically important difference for treatment of tardive dyskinesia with deutetrabenazine, according to a poster presented at Psych Congress 2020. 
A decrease of 3 points on the Abnormal Involuntary Movement Scale score is the minimal clinically important difference for treatment of tardive dyskinesia with deutetrabenazine, according to a poster presented at Psych Congress 2020. 
A decrease of 3 points on the...
10/01/2020
Psych Congress Network
Improving Outcomes in ADHD Through Early Treatment
Videos
Improving Outcomes in ADHD Through Early Treatment
09/23/2020
Psych Congress 2020 presenter c, discusses the ways in which early treatment can improve outcomes in patients with attention-deficit/hyperactivity disorder (ADHD). 
Psych Congress 2020 presenter c, discusses the ways in which early treatment can improve outcomes in patients with attention-deficit/hyperactivity disorder (ADHD). 
Psych Congress 2020 presenter c,...
09/23/2020
Psych Congress Network
News
Targeted Exposure to Stress Can Improve Depressive Symptoms
09/13/2020
Introducing time-limited adaptive stressors has demonstrated a profound effect on patient well-being, but efforts to sidestep stress often overshadow these approaches in today's society, Psych Congress 2020 cochair Charles Raison, MD, said at...
Introducing time-limited adaptive stressors has demonstrated a profound effect on patient well-being, but efforts to sidestep stress often overshadow these approaches in today's society, Psych Congress 2020 cochair Charles Raison, MD, said at...
Introducing time-limited...
09/13/2020
Psych Congress Network
Optimizing Response to Bipolar Disorder Treatment
Videos
Optimizing Response to Bipolar Disorder Treatment
09/13/2020
Psych Congress 2020 speaker Joseph F. Goldberg, MD, details factors that could influence a patient's response to a treatment for bipolar disorder, and how clinicians can address them.
Psych Congress 2020 speaker Joseph F. Goldberg, MD, details factors that could influence a patient's response to a treatment for bipolar disorder, and how clinicians can address them.
Psych Congress 2020 speaker...
09/13/2020
Psych Congress Network
Adjusting Psychopharmacologic Treatment for Geriatric Patients
Videos
Adjusting Psychopharmacologic Treatment for Geriatric Patients
09/13/2020
Psych Congress 2020 speaker Marc E. Agronin, MD, shares strategies that mental health clinicians can use to adjust psychopharmacologic treatment and dosages for geriatric patients.
Psych Congress 2020 speaker Marc E. Agronin, MD, shares strategies that mental health clinicians can use to adjust psychopharmacologic treatment and dosages for geriatric patients.
Psych Congress 2020 speaker Marc...
09/13/2020
Psych Congress Network
News
Study Finds Improved MDD Outcomes With Pharmacogenomic Test
09/13/2020
A pharmacogenomic test was associated with improved outcomes in patients with major depressive disorder who failed to improve with previous antidepressant treatment, according to a meta-analysis presented at Psych Congress 2020.
A pharmacogenomic test was associated with improved outcomes in patients with major depressive disorder who failed to improve with previous antidepressant treatment, according to a meta-analysis presented at Psych Congress 2020.
A pharmacogenomic test was...
09/13/2020
Psych Congress Network
Poster
Add-on Pimavanserin Improves Insomnia, Sleepiness in MDD Study
09/13/2020
A secondary analysis of a study investigating adjunctive pimavanserin for the treatment of patients with major depressive disorder found that it significantly improved insomnia and sleepiness, researchers reported at Psych Congress 2020. 
A secondary analysis of a study investigating adjunctive pimavanserin for the treatment of patients with major depressive disorder found that it significantly improved insomnia and sleepiness, researchers reported at Psych Congress 2020. 
A secondary analysis of a study...
09/13/2020
Psych Congress Network
The Occurrence of Cognitive Deficits Across Psychiatric Disorders
Videos
The Occurrence of Cognitive Deficits Across Psychiatric Disorders
09/12/2020
Bernhard T. Baune, PhD, MD, head of the Department of Mental Health at the University of Münster, Germany, discusses the occurrence of cognitive deficits in patients with various psychiatric disorders.
Bernhard T. Baune, PhD, MD, head of the Department of Mental Health at the University of Münster, Germany, discusses the occurrence of cognitive deficits in patients with various psychiatric disorders.
Bernhard T. Baune, PhD, MD, head...
09/12/2020
Psych Congress Network
Updates in Adult-Onset ADHD With Dr. Vladimir Maletic
Videos
Updates in Adult-Onset ADHD With Dr. Vladimir Maletic
09/12/2020
Psych Congress 2020 cochair Vladimir Maletic, MD, MS, gives the latest updates on adult-onset attention deficit/hyperactivity disorder (ADHD).
Psych Congress 2020 cochair Vladimir Maletic, MD, MS, gives the latest updates on adult-onset attention deficit/hyperactivity disorder (ADHD).
Psych Congress 2020 cochair...
09/12/2020
Psych Congress Network
Dr. Timothy Wilens on Negative Outcomes Associated With Untreated ADHD
Videos
Dr. Timothy Wilens on Negative Outcomes Associated With Untreated ADHD
09/12/2020
Psych Congress 2020 presenter Timothy Wilens, MD, discusses the negative outcomes associated with attention-deficit/hyperactivity disorder (ADHD) that is left untreated.
Psych Congress 2020 presenter Timothy Wilens, MD, discusses the negative outcomes associated with attention-deficit/hyperactivity disorder (ADHD) that is left untreated.
Psych Congress 2020 presenter...
09/12/2020
Psych Congress Network
News
Simple Solutions Can Help Providers Manage Side Effects
09/12/2020
In managing side effects associated with psychotropic drugs, prescribers need to arm themselves with a menu of strategies and opt first for simpler solutions over adding or switching a medication, Rajnish Mago, MD, said at Psych Congress 2020.
In managing side effects associated with psychotropic drugs, prescribers need to arm themselves with a menu of strategies and opt first for simpler solutions over adding or switching a medication, Rajnish Mago, MD, said at Psych Congress 2020.
In managing side effects...
09/12/2020
Psych Congress Network
News
Linked EHR, Claims Data Provide Glimpse of Real-World Antidepressant Adherence
09/12/2020
Patients with major depressive disorder had significantly lower odds of filling a written prescription for a new antidepressant if they were nonwhite and antidepressant-naïve, according to an investigation presented in a poster at Psych...
Patients with major depressive disorder had significantly lower odds of filling a written prescription for a new antidepressant if they were nonwhite and antidepressant-naïve, according to an investigation presented in a poster at Psych...
Patients with major depressive...
09/12/2020
Psych Congress Network
News
Lurasidone Eases Manic Symptoms in Youth With Bipolar Depression
09/11/2020
Up to 2 years of treatment with lurasidone improved manic symptoms in children and adolescents with bipolar depression, according to a poster presented at Psych Congress 2020.
Up to 2 years of treatment with lurasidone improved manic symptoms in children and adolescents with bipolar depression, according to a poster presented at Psych Congress 2020.
Up to 2 years of treatment with...
09/11/2020
Psych Congress Network
News
The Importance of Weighing Options When Treating Postpartum Disorders
09/11/2020
Many women experience an even greater vulnerability to psychiatric crisis in the postpartum period than during pregnancy, requiring a careful balancing of needs that should prioritize the mother's health, Marlene Freeman, MD, said at Psych...
Many women experience an even greater vulnerability to psychiatric crisis in the postpartum period than during pregnancy, requiring a careful balancing of needs that should prioritize the mother's health, Marlene Freeman, MD, said at Psych...
Many women experience an even...
09/11/2020
Psych Congress Network
News
Clinicians Gaining Deeper Understanding of DMDD in Children
09/10/2020
Clinicians could be on the brink of a much greater understanding of the relatively new diagnosis of disruptive mood dysregulation disorder (DMDD) in children, including evidence on the most promising direction in treatment, Julie Carbray,...
Clinicians could be on the brink of a much greater understanding of the relatively new diagnosis of disruptive mood dysregulation disorder (DMDD) in children, including evidence on the most promising direction in treatment, Julie Carbray,...
Clinicians could be on the brink...
09/10/2020
Psych Congress Network
News
Psychedelics Bring Patients Face-to-Face with Underlying Issues
09/10/2020
The use of psychedelics in psychotherapy can help patients go beyond ameliorating symptoms and confront their root causes of depression, Andrew D. Penn, RN, MS, NP, CNS, APRN-BC, and Charles Raison, MD, said at a session at the Psych Congress...
The use of psychedelics in psychotherapy can help patients go beyond ameliorating symptoms and confront their root causes of depression, Andrew D. Penn, RN, MS, NP, CNS, APRN-BC, and Charles Raison, MD, said at a session at the Psych Congress...
The use of psychedelics in...
09/10/2020
Psych Congress Network
Clinical Characteristics Affecting Response to Bipolar Disorder Treatment
Videos
Clinical Characteristics Affecting Response to Bipolar Disorder Treatment
09/10/2020
Joseph F. Goldberg, MD, explains which clinical characteristics of a patient could affect their response to a treatment for bipolar disorder.
Joseph F. Goldberg, MD, explains which clinical characteristics of a patient could affect their response to a treatment for bipolar disorder.
Joseph F. Goldberg, MD, explains...
09/10/2020
Psych Congress Network
News
Adjunctive Brexpiprazole Enhances Calming, Engagement in MDD
09/10/2020
Patients with major depressive disorder (MDD) reported feeling calmer and more engaged after treatment with adjunctive brexpiprazole, according to a poster presented at Psych Congress 2020.
Patients with major depressive disorder (MDD) reported feeling calmer and more engaged after treatment with adjunctive brexpiprazole, according to a poster presented at Psych Congress 2020.
Patients with major depressive...
09/10/2020
Psych Congress Network
The Prevalence of Cognitive Dysfunction in Major Depressive Disorder
Videos
The Prevalence of Cognitive Dysfunction in Major Depressive Disorder
09/10/2020
Bernhard T. Baune, PhD, MD, discusses the prevalence of cognitive dysfunction in people with major depressive disorder. Dr. Baune, of the University of Münster, Germany, spoke at the Psych Congress 2020 preconference on psychopharmacology.
Bernhard T. Baune, PhD, MD, discusses the prevalence of cognitive dysfunction in people with major depressive disorder. Dr. Baune, of the University of Münster, Germany, spoke at the Psych Congress 2020 preconference on psychopharmacology.
Bernhard T. Baune, PhD, MD,...
09/10/2020
Psych Congress Network
Dr. Jonathan Meyer on Treating Schizophrenia: Lessons Learned and Future Directions
Podcasts
Dr. Jonathan Meyer on Treating Schizophrenia: Lessons Learned and Future Directions
09/09/2020
In this podcast, Jonathan Meyer, MD, discusses the role of D2 antagonism in schizophrenia treatment, lessons learned about schizophrenia treatment from clozapine, and emerging treatments for schizophrenia and their therapeutic targets.
In this podcast, Jonathan Meyer, MD, discusses the role of D2 antagonism in schizophrenia treatment, lessons learned about schizophrenia treatment from clozapine, and emerging treatments for schizophrenia and their therapeutic targets.
In this podcast, Jonathan Meyer,...
09/09/2020
Psych Congress Network
Preventing the Progression of Bipolar Disorder
Videos
Preventing the Progression of Bipolar Disorder
09/09/2020
Robert M. Post, MD, discusses the need for early intervention in bipolar disorder, steps which should be taken after a patient’s first manic episode, and factors to consider when choosing a mood stabilizer for a patient with bipolar disorder.
Robert M. Post, MD, discusses the need for early intervention in bipolar disorder, steps which should be taken after a patient’s first manic episode, and factors to consider when choosing a mood stabilizer for a patient with bipolar disorder.
Robert M. Post, MD, discusses...
09/09/2020
Psych Congress Network
Blog
Psych Congress to Bring Psychedelic-Assisted Therapies Into Focus
09/03/2020
BLOG: Psychedelic-assisted therapies, once consigned to the fringes of psychiatric practice, are exploding into the mainstream of psychiatry and will take center stage at a Psych Congress preconference.
BLOG: Psychedelic-assisted therapies, once consigned to the fringes of psychiatric practice, are exploding into the mainstream of psychiatry and will take center stage at a Psych Congress preconference.
BLOG: Psychedelic-assisted...
09/03/2020
Psych Congress Network
7 Habits to Develop to Treat Anxiety Disorders Effectively: Part 7
Videos
7 Habits to Develop to Treat Anxiety Disorders Effectively: Part 7
09/01/2020
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the seventh of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the seventh of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
Psych Congress Steering...
09/01/2020
Psych Congress Network
7 Habits to Develop to Treat Anxiety Disorders Effectively: Part 6
Videos
7 Habits to Develop to Treat Anxiety Disorders Effectively: Part 6
09/01/2020
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the sixth of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the sixth of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
Psych Congress Steering...
09/01/2020
Psych Congress Network
7 Habits to Develop to Treat Anxiety Disorders Effectively: Part 5
Videos
7 Habits to Develop to Treat Anxiety Disorders Effectively: Part 5
08/31/2020
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the fifth of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the fifth of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
Psych Congress Steering...
08/31/2020
Psych Congress Network
7 Habits to Develop to Treat Anxiety Disorders Effectively: Part 4
Videos
7 Habits to Develop to Treat Anxiety Disorders Effectively: Part 4
08/28/2020
In this video, Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the fourth of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
In this video, Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the fourth of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
In this video, Psych...
08/28/2020
Psych Congress Network
7 Habits to Develop to Treat Anxiety Disorders Effectively: Part 3
Videos
7 Habits to Develop to Treat Anxiety Disorders Effectively: Part 3
08/26/2020
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the third of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the third of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
Psych Congress Steering...
08/26/2020
Psych Congress Network
News
Combining Ketamine With Psychotherapy to Treat Depression
08/24/2020
A session being presented at Psych Congress 2020 will educate attendees on the practice of combining ketamine treatment with psychotherapy for patients with treatment-resistant depression (TRD).
A session being presented at Psych Congress 2020 will educate attendees on the practice of combining ketamine treatment with psychotherapy for patients with treatment-resistant depression (TRD).
A session being presented at...
08/24/2020
Psych Congress Network
Treating Children and Adolescents Via Telepsychiatry
Videos
Treating Children and Adolescents Via Telepsychiatry
08/24/2020
In this installment of "Coping During COVID-19," Psych Congress Steering Committee member Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, shares tips and learnings for treating children and adolescents via telepsychiatry.
In this installment of "Coping During COVID-19," Psych Congress Steering Committee member Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, shares tips and learnings for treating children and adolescents via telepsychiatry.
In this installment of "Coping...
08/24/2020
Psych Congress Network
7 Habits to Develop to Treat Anxiety Disorders Effectively: Part 2
Videos
7 Habits to Develop to Treat Anxiety Disorders Effectively: Part 2
08/24/2020
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the second of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the second of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
Psych Congress Steering...
08/24/2020
Psych Congress Network
Blog
Treating Patients Who Have Made Cannabis Their Medicine
08/19/2020
BLOG: More patients are exploring the medicinal aspects of cannabis for their psychiatric conditions, and many are presenting to their providers already convinced of the benefits of their self-treatments.
BLOG: More patients are exploring the medicinal aspects of cannabis for their psychiatric conditions, and many are presenting to their providers already convinced of the benefits of their self-treatments.
BLOG: More patients are...
08/19/2020
Psych Congress Network
7 Habits to Develop to Treat Anxiety Disorders Effectively: Part 1
Videos
7 Habits to Develop to Treat Anxiety Disorders Effectively: Part 1
08/18/2020
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the first of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the first of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
Psych Congress Steering...
08/18/2020
Psych Congress Network
The Relationship Between Inflammation and Mental Illnesses
Videos
The Relationship Between Inflammation and Mental Illnesses
08/13/2020
In this video, Psych Congress 2020 cochair Charles Raison, MD, discusses the relationship between inflammation and mental illnesses, and misconceptions about the connection between the two.
In this video, Psych Congress 2020 cochair Charles Raison, MD, discusses the relationship between inflammation and mental illnesses, and misconceptions about the connection between the two.
In this video, Psych...
08/13/2020
Psych Congress Network
Videos
Treatment Approaches for Patients With Depression and Substance Use Disorders
12/19/2019
W. Clay Jackson, MD, DipTh, of the University of Tennessee College of Medicine in Memphis, discusses treatment approaches for patients with depression and substance use disorders.
W. Clay Jackson, MD, DipTh, of the University of Tennessee College of Medicine in Memphis, discusses treatment approaches for patients with depression and substance use disorders.
W. Clay Jackson, MD, DipTh, of...
12/19/2019
Psych Congress Network
Videos
Detecting Mixed Features in Major Depression
12/05/2019
W. Clay Jackson, MD, DipTh, explains the difference between major depressive disorder and major depressive disorder with mixed features.
W. Clay Jackson, MD, DipTh, explains the difference between major depressive disorder and major depressive disorder with mixed features.
W. Clay Jackson, MD, DipTh,...
12/05/2019
Psych Congress Network
Videos
Best Practices for Administering Esketamine
11/07/2019
Sanjay J. Mathew, MD, speaks about best practices for administering esketamine during his Psych Congress 2019 presentation "Top 5 Issues Clinicians Should Know about Ketamine Therapy."
Sanjay J. Mathew, MD, speaks about best practices for administering esketamine during his Psych Congress 2019 presentation "Top 5 Issues Clinicians Should Know about Ketamine Therapy."
Sanjay J. Mathew, MD, speaks...
11/07/2019
Psych Congress Network
Videos
Q&A With Phillip J. Resnick on School Shootings
11/01/2019
In this video, forensic psychiatrist Phillip J. Resnick, MD discusses common traits in school shooters, misconceptions people have about school shooters, and how mental health clinicians can help prevent school shootings.
In this video, forensic psychiatrist Phillip J. Resnick, MD discusses common traits in school shooters, misconceptions people have about school shooters, and how mental health clinicians can help prevent school shootings.
In this video, forensic...
11/01/2019
Psych Congress Network
Videos
Using Thyroid Hormone in Depression Treatment
10/28/2019
Michael Thase, MD, discusses when clinicians should consider using thyroid hormone as an antidepressant augmentation strategy and possible risks of the approach.
Michael Thase, MD, discusses when clinicians should consider using thyroid hormone as an antidepressant augmentation strategy and possible risks of the approach.
Michael Thase, MD, discusses...
10/28/2019
Psych Congress Network
Early Healthy Habits Can Help Stave Off Late-Life Brain Degeneration
10/09/2019
SAN DIEGO—While medications can address some of the symptoms of Alzheimer’s disease, maintaining a healthy lifestyle can delay its onset and slow progression of the disease, a geriatric psychiatry expert told attendees at Psych Congress 2019.
SAN DIEGO—While medications can address some of the symptoms of Alzheimer’s disease, maintaining a healthy lifestyle can delay its onset and slow progression of the disease, a geriatric psychiatry expert told attendees at Psych Congress 2019.
SAN DIEGO—While medications can...
10/09/2019
Psych Congress Network
How Mental Health Clinicians Can Help Prevent School Violence
10/06/2019
SAN DIEGO—There is no single profile of a school shooter, and potential threats must be evaluated based on the behavior of the student instead, forensic psychiatrist Phillip J. Resnick, MD, said at a Psych Congress 2019 Featured Session on...
SAN DIEGO—There is no single profile of a school shooter, and potential threats must be evaluated based on the behavior of the student instead, forensic psychiatrist Phillip J. Resnick, MD, said at a Psych Congress 2019 Featured Session on...
SAN DIEGO—There is no single...
10/06/2019
Psych Congress Network
Clinicians Urged Not to Sidestep Patient Sexual Dysfunction
10/05/2019
SAN DIEGO—Mental health clinicians aren't talking to their patients enough about sexual dysfunction issues that could be resulting from use of antidepressants or the underlying depressive illness, University of Virginia Professor of...
SAN DIEGO—Mental health clinicians aren't talking to their patients enough about sexual dysfunction issues that could be resulting from use of antidepressants or the underlying depressive illness, University of Virginia Professor of...
SAN DIEGO—Mental health...
10/05/2019
Psych Congress Network
News
Psilocybin-Assisted Therapy Showing Promise, but More Research Needed
10/05/2019
SAN DIEGO—Psilocybin-assisted psychotherapy is showing promise in research examining effects on depressive symptoms and substance use, but no trials have reached phase 3 and eventual approval of the treatment remains uncertain, a researcher...
SAN DIEGO—Psilocybin-assisted psychotherapy is showing promise in research examining effects on depressive symptoms and substance use, but no trials have reached phase 3 and eventual approval of the treatment remains uncertain, a researcher...
SAN DIEGO—Psilocybin-assisted...
10/05/2019
Psych Congress Network
ALKS 3831 Well-Tolerated in Extension Study for Schizophrenia
10/05/2019
SAN DIEGO—A year’s treatment with the investigational drug ALKS 3831 was generally well-tolerated and demonstrated a safety profile that supports long-term use, according to study findings presented during a poster session at Psych Congress...
SAN DIEGO—A year’s treatment with the investigational drug ALKS 3831 was generally well-tolerated and demonstrated a safety profile that supports long-term use, according to study findings presented during a poster session at Psych Congress...
SAN DIEGO—A year’s treatment...
10/05/2019
Psych Congress Network
CBD Popularity Soars as Much About It Remains Unknown
10/05/2019
SAN DIEGO—Cannabidiol (CBD) has quickly entered the mainstream, but there is a dearth of evidence about the effects of the cannabis byproduct, a speaker told a large audience at Psych Congress 2019.
SAN DIEGO—Cannabidiol (CBD) has quickly entered the mainstream, but there is a dearth of evidence about the effects of the cannabis byproduct, a speaker told a large audience at Psych Congress 2019.
SAN DIEGO—Cannabidiol (CBD) has...
10/05/2019
Psych Congress Network
Lofexidine Demonstrates Efficacy During Early Opioid Withdrawal
10/05/2019
SAN DIEGO—The opioid withdrawal drug lofexidine demonstrated statistically significant efficacy across a half-dozen patient- and clinician-reported outcomes during the first 7 days after immediate opioid cessation, according to study...
SAN DIEGO—The opioid withdrawal drug lofexidine demonstrated statistically significant efficacy across a half-dozen patient- and clinician-reported outcomes during the first 7 days after immediate opioid cessation, according to study...
SAN DIEGO—The opioid withdrawal...
10/05/2019
Psych Congress Network
In Children With Bipolar Disorder, Antipsychotic Choice May Affect Hospitalization Risk
10/04/2019
SAN DIEGO—Children with bipolar disorder who were treated with lurasidone had a lower risk of all-cause and psychiatric-related hospitalization than those treated with aripiprazole or olanzapine, according to a retrospective claims database...
SAN DIEGO—Children with bipolar disorder who were treated with lurasidone had a lower risk of all-cause and psychiatric-related hospitalization than those treated with aripiprazole or olanzapine, according to a retrospective claims database...
SAN DIEGO—Children with bipolar...
10/04/2019
Psych Congress Network
ADHD, Bariatric Surgery May Boost Suicidality in People With BED
10/04/2019
SAN DIEGO—People with binge eating disorder are at increased risk of suicidal ideation and suicide attempt—and that risk appears even greater if they also have attention-deficit/hyperactivity disorder or have had bariatric surgery.​​​​​​​
SAN DIEGO—People with binge eating disorder are at increased risk of suicidal ideation and suicide attempt—and that risk appears even greater if they also have attention-deficit/hyperactivity disorder or have had bariatric surgery.​​​​​​​
SAN DIEGO—People with binge...
10/04/2019
Psych Congress Network
Treatment Patterns for Depressive Episodes May Signal Poor Care Personalization
10/04/2019
SAN DIEGO—Clinicians tend to decrease monotherapy and increase adjunctive therapy when patients with major depressive disorder experience major depressive episodes, according to research presented at Psych Congress 2019.
SAN DIEGO—Clinicians tend to decrease monotherapy and increase adjunctive therapy when patients with major depressive disorder experience major depressive episodes, according to research presented at Psych Congress 2019.
SAN DIEGO—Clinicians tend to...
10/04/2019
Psych Congress Network
Pimavanserin Improves Sexual Function in Patients With MDD
10/04/2019
SAN DIEGO—When added to ongoing treatment, pimavanserin significantly improved sexual function in patients with major depressive disorder, according to study results shared during poster sessions at Psych Congress 2019.
SAN DIEGO—When added to ongoing treatment, pimavanserin significantly improved sexual function in patients with major depressive disorder, according to study results shared during poster sessions at Psych Congress 2019.
SAN DIEGO—When added to ongoing...
10/04/2019
Psych Congress Network
News
Esketamine Quickly Reduces Depressive Symptoms in Patients at Risk of Suicide
10/04/2019
SAN DIEGO—Added to standard-of-care treatment, esketamine nasal spray rapidly reduced depressive symptoms in patients at imminent risk of suicide, according to two phase 3 trials presented at Psych Congress 2019.
SAN DIEGO—Added to standard-of-care treatment, esketamine nasal spray rapidly reduced depressive symptoms in patients at imminent risk of suicide, according to two phase 3 trials presented at Psych Congress 2019.
SAN DIEGO—Added to...
10/04/2019
Psych Congress Network
Evidence Supports Mindfulness Meditation for Anxiety, Depression
10/04/2019
SAN DIEGO—Mindfulness meditation is an effective, evidence-based treatment which can improve symptoms of anxiety, depression, and other mental health conditions, two speakers told attendees at a Psych Congress 2019 session.
SAN DIEGO—Mindfulness meditation is an effective, evidence-based treatment which can improve symptoms of anxiety, depression, and other mental health conditions, two speakers told attendees at a Psych Congress 2019 session.
SAN DIEGO—Mindfulness meditation...
10/04/2019
Psych Congress Network
Robust Treatment Options Remain Limited for Stimulant Use Disorder
10/04/2019
SAN DIEGO—Prescribers treating stimulant use disorders remain limited to off-label medication options at a time when stimulant use and overdose rates are on the rise.
SAN DIEGO—Prescribers treating stimulant use disorders remain limited to off-label medication options at a time when stimulant use and overdose rates are on the rise.
SAN DIEGO—Prescribers treating...
10/04/2019
Psych Congress Network
Care Guided by Pharmacogenomic Testing May Benefit Patients With Possible Gene-Drug Interactions
10/04/2019
SAN DIEGO—Combinatorial pharmacogenomic testing offers clinical utility for patients with major depressive disorder who have failed to respond to medication for genetic reasons, according to a study presented at Psych Congress 2019.
SAN DIEGO—Combinatorial pharmacogenomic testing offers clinical utility for patients with major depressive disorder who have failed to respond to medication for genetic reasons, according to a study presented at Psych Congress 2019.
SAN DIEGO—Combinatorial...
10/04/2019
Psych Congress Network
Oral Antipsychotic Side Effects ‘Bothersome,’ Say Patients With Bipolar Disorder
10/04/2019
SAN DIEGO—Side effects were experienced nearly universally by respondents in an online survey who took oral antipsychotics the previous year for bipolar I disorder, according to results presented at a Psych Congress 2019 poster session.
SAN DIEGO—Side effects were experienced nearly universally by respondents in an online survey who took oral antipsychotics the previous year for bipolar I disorder, according to results presented at a Psych Congress 2019 poster session.
SAN DIEGO—Side effects were...
10/04/2019
Psych Congress Network
News
Many With Schizophrenia Doubt Overall Benefit of Oral Antipsychotics
10/04/2019
SAN DIEGO—Just half of survey respondents who took oral antipsychotics for schizophrenia thought the medication did more good than harm, according to research presented during poster sessions at Psych Congress 2019.
SAN DIEGO—Just half of survey respondents who took oral antipsychotics for schizophrenia thought the medication did more good than harm, according to research presented during poster sessions at Psych Congress 2019.
SAN DIEGO—Just half of survey...
10/04/2019
Psych Congress Network
MDD Relapse Boosts Healthcare Use, Costs
10/04/2019
SAN DIEGO—Major depressive disorder relapse is linked with higher health care utilization and costs, researchers reported during a poster session at Psych Congress 2019.
SAN DIEGO—Major depressive disorder relapse is linked with higher health care utilization and costs, researchers reported during a poster session at Psych Congress 2019.
SAN DIEGO—Major depressive...
10/04/2019
Psych Congress Network
Patients Driving Need for Psychiatrists to Learn More About Genetics
10/04/2019
SAN DIEGO—Psychiatrists need more knowledge of genetics because patients are coming to them armed with questions, and often their own genetic test results. But provider training has lagged, and the use of genetic data to inform treatment...
SAN DIEGO—Psychiatrists need more knowledge of genetics because patients are coming to them armed with questions, and often their own genetic test results. But provider training has lagged, and the use of genetic data to inform treatment...
SAN DIEGO—Psychiatrists need...
10/04/2019
Psych Congress Network
News
Momentum Grows for Psychedelics as Part of Mainstream Therapy
10/03/2019
SAN DIEGO—With much of the historical fear around psychedelics having dissipated, the founder of the Multidisciplinary Association for Psychedelic Studies (MAPS) sees current research as leading the field to the emergence of a new branch of...
SAN DIEGO—With much of the historical fear around psychedelics having dissipated, the founder of the Multidisciplinary Association for Psychedelic Studies (MAPS) sees current research as leading the field to the emergence of a new branch of...
SAN DIEGO—With much of the...
10/03/2019
Psych Congress Network
Using Data to Better Understand Patients and Their Mental Health
10/03/2019
SAN DIEGO—Data has the power to give mental health clinicians a better understanding of patients and their well-being, and today’s technology can easily collect and disseminate that data, physician and entrepreneur Arshya Vahabzadeh, MD, told...
SAN DIEGO—Data has the power to give mental health clinicians a better understanding of patients and their well-being, and today’s technology can easily collect and disseminate that data, physician and entrepreneur Arshya Vahabzadeh, MD, told...
SAN DIEGO—Data has the power to...
10/03/2019
Psych Congress Network
Supportive Care Essential to Maximize Effectiveness of Buprenorphine for Opioid Addiction
10/03/2019
SAN DIEGO—Medication treatments such as buprenorphine are allowing physicians to address opioid use disorder (OUD) successfully, but medication alone is not sufficient to bring about a stable recovery in patients, Arwen Podesta, MD, said at...
SAN DIEGO—Medication treatments such as buprenorphine are allowing physicians to address opioid use disorder (OUD) successfully, but medication alone is not sufficient to bring about a stable recovery in patients, Arwen Podesta, MD, said at...
SAN DIEGO—Medication treatments...
10/03/2019
Psych Congress Network
Managing Patients With Opioid Use Disorder and Chronic Pain
10/03/2019
SAN DIEGO—Mental health clinicians will likely be taking on many more patients with opioid use disorder, as 40% of primary care providers will not accept any new patients who take opioids, an expert said at Psych Congress 2019.
SAN DIEGO—Mental health clinicians will likely be taking on many more patients with opioid use disorder, as 40% of primary care providers will not accept any new patients who take opioids, an expert said at Psych Congress 2019.
SAN DIEGO—Mental health...
10/03/2019
Psych Congress Network
News
Exploring the Role of GABA in Psychiatric Treatment
10/02/2019
SAN DIEGO—Charles F. Zorumski, MD, presented an update on gamma-aminobutyric acid (GABA), a complex neurotransmitter he has been studying for more 30 years, at the Psych Congress 2019 Practical Psychopharmacology Pre-Conference.
SAN DIEGO—Charles F. Zorumski, MD, presented an update on gamma-aminobutyric acid (GABA), a complex neurotransmitter he has been studying for more 30 years, at the Psych Congress 2019 Practical Psychopharmacology Pre-Conference.
SAN DIEGO—Charles F. Zorumski,...
10/02/2019
Psych Congress Network
News
Assessing Suicidal Ideation and Behaviors in Patients
10/02/2019
SAN DIEGO—Mental health clinicians should assess patients’ past and present suicidal ideation and behaviors, both regularly and during times of stress, an expert said at the Psych Congress 2019 Suicide Prevention 360 Pre-Conference.
SAN DIEGO—Mental health clinicians should assess patients’ past and present suicidal ideation and behaviors, both regularly and during times of stress, an expert said at the Psych Congress 2019 Suicide Prevention 360 Pre-Conference.
SAN DIEGO—Mental health...
10/02/2019
Psych Congress Network
News
How Safety Planning Can Help Prevent Suicides
10/01/2019
SAN DIEGO—A safety plan is a powerful resource which mental health clinicians can develop with their patients to help prevent suicidal behaviors, a speaker at the Psych Congress 2019 Suicide Prevention 360 Pre-Conference said.
SAN DIEGO—A safety plan is a powerful resource which mental health clinicians can develop with their patients to help prevent suicidal behaviors, a speaker at the Psych Congress 2019 Suicide Prevention 360 Pre-Conference said.
SAN DIEGO—A safety plan is a...
10/01/2019
Psych Congress Network
Get the Full 2019 Psych Congress Preview
09/30/2019
Click on the image below to view or download the full official 2019 Psych Congress preview.
Click on the image below to view or download the full official 2019 Psych Congress preview.
Click on the image below to view...
09/30/2019
Psych Congress Network
Psych Congress 2019: Session and Speaker Spotlight
09/27/2019
Get a behind-the-scenes look at some of the sessions taking place at the 32nd annual Psych Congress, and meet the experts presenting them.
Get a behind-the-scenes look at some of the sessions taking place at the 32nd annual Psych Congress, and meet the experts presenting them.
Get a behind-the-scenes look at...
09/27/2019
Psych Congress Network
Stopping the Surge of School Shootings
09/23/2019
Phillip Resnick, MD, a psychiatry professor at Case Western Reserve University, Cleveland, Ohio, will brief mental health providers on how to recognize potential school shooters in their own practices at Psych Congress 2019.
Phillip Resnick, MD, a psychiatry professor at Case Western Reserve University, Cleveland, Ohio, will brief mental health providers on how to recognize potential school shooters in their own practices at Psych Congress 2019.
Phillip Resnick, MD, a...
09/23/2019
Psych Congress Network
News
Psych Congress Launches Suicide Prevention 360 Initiative in Partnership With the American Foundation for Suicide Prevention
09/18/2019
In concurrence with National Suicide Prevention Month, HMP, a leading healthcare education and events company, announced the launch of the Suicide Prevention 360 initiative.
In concurrence with National Suicide Prevention Month, HMP, a leading healthcare education and events company, announced the launch of the Suicide Prevention 360 initiative.
In concurrence with National...
09/18/2019
Psych Congress Network
Psych Congress Announces Prominent Additions to Steering Committee
09/17/2019
Psych Congress has announced three new mental health experts will join its Steering Committee.
Psych Congress has announced three new mental health experts will join its Steering Committee.
Psych Congress has announced...
09/17/2019
Psych Congress Network
How Technological Advances Could Transform Psychiatry
09/16/2019
Arshya Vahabzadeh, MD, understands the power neurotechnology can have in the lives of patients. The technology expert recently shared some thoughts on the future of psychiatry, which he will expand upon during his featured session at Psych...
Arshya Vahabzadeh, MD, understands the power neurotechnology can have in the lives of patients. The technology expert recently shared some thoughts on the future of psychiatry, which he will expand upon during his featured session at Psych...
Arshya Vahabzadeh, MD,...
09/16/2019
Psych Congress Network
News
American Foundation for Suicide Prevention Named Psych Congress 2019 Charitable Partner
09/10/2019
Psych Congress is pleased to announce on World Suicide Prevention Day that our 2019 charitable partner for the upcoming Congress in San Diego is the American Foundation for Suicide Prevention (AFSP).
Psych Congress is pleased to announce on World Suicide Prevention Day that our 2019 charitable partner for the upcoming Congress in San Diego is the American Foundation for Suicide Prevention (AFSP).
Psych Congress is pleased to...
09/10/2019
Psych Congress Network
Blog
Cannabidiol Popularity Raises Questions for Clinicians
09/04/2019
BLOG: Currently, many of our patients are using cannabinoids, especially cannabidiol (CBD) to treat their own symptoms—ranging from insomnia, to anxiety, to depression.
BLOG: Currently, many of our patients are using cannabinoids, especially cannabidiol (CBD) to treat their own symptoms—ranging from insomnia, to anxiety, to depression.
BLOG: Currently, many of our...
09/04/2019
Psych Congress Network
News
MDMA Moving Closer to Therapeutic Use
08/14/2019
A leading researcher on psychedelics sees late 2021 as the target date for MDMA to complete the transition from perceived party drug to legitimate prescription medication.
A leading researcher on psychedelics sees late 2021 as the target date for MDMA to complete the transition from perceived party drug to legitimate prescription medication.
A leading researcher on...
08/14/2019
Psych Congress Network
Advancements Aim to Build Trust in ECT
08/08/2019
Developments Seek to Demonstrate Safety and Efficacy A series of advances in electroconvulsive therapy (ECT) have been made recently, with the aim of facilitating safe and effective use of the treatment for patients with certain severe...
Developments Seek to Demonstrate Safety and Efficacy A series of advances in electroconvulsive therapy (ECT) have been made recently, with the aim of facilitating safe and effective use of the treatment for patients with certain severe...
Developments Seek to Demonstrate...
08/08/2019
Psych Congress Network
The Triple Threat of Substance Abuse, Chronic Pain, and Psychiatric Disorders
07/31/2019
Substance Use Disorder and Chronic Pain Rates Elevated in Psychiatric Patients The lifetime prevalence of a substance use disorder (SUD) hovers around 20% in the general population. The lifetime prevalence of chronic pain is about the...
Substance Use Disorder and Chronic Pain Rates Elevated in Psychiatric Patients The lifetime prevalence of a substance use disorder (SUD) hovers around 20% in the general population. The lifetime prevalence of chronic pain is about the...
Substance Use Disorder and...
07/31/2019
Psych Congress Network

Advertisement

About

Celebrating 35 years of empowering the highest standard in mental healthcare, Psych Congress serves as a unique, integrated forum to connect members of the entire mental health team—bringing together psychiatrists, nurse practitioners, physician assistants, psychologists, primary care physicians, and other mental health professionals for 4 days of practical education to improve patient care.

Advertisement

December 9 ⁠–⁠ December 11
Psych Congress Primary Care Online Series
December 12 ⁠–⁠ December 13
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
May 28 ⁠–⁠ May 31
See Full Calendar

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement